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Preface
The idea of this book came about due to the increasing number of case reports in
the medical literature on non-tubal ectopic pregnancies, which is mainly due to
the increased number of cesarean sections and assisted reproduction. There is no
consensus in the literature about the best treatment, therefore non-tubal ectopic
pregnancy is still a challenge for obstetricians. Innumerous innovations in the
diagnosis and management of non-tubal ectopic pregnancies have occurred in the
recent years and this book offers an immersion on the subject. Throughout the book
the reader is invited to visit the most important issues related to non-tubal ectopic
pregnancies.
Non-tubal ectopic pregnancies presents serious complications, which are greater
than in tubal pregnancies. Therefore, the maternal morbidity and mortality are
higher. Due to this, an early diagnosis is crucial for the best result of the treatment. 
In this book we present the challenges and pitfalls for diagnosis.
In the various chapters, the authors contemplate the management of different
types of non-tubal ectopic pregnancies such as cervical, interstitial, cesarean scar, 
ovarian, and abdominal pregnancy to which several modalities of treatment are
presented: surgery, local treatment with methotrexate, systemic treatment with
MTX, embolization, and specific treatments for the different sites of non-tubal 
pregnancy.
The book presents the most relevant aspects of the non-tubal ectopic pregnancy
scenario. Authors from all over the world who have contributed to this book are
experts in their areas and offer readers the best from their research.
Our intention is for the reader to be presented with the latest updates on non-tubal 
ectopic pregnancies.
I would like to thank my wife, Camila, and our children, João and Pedro, for their
support, understanding, and love during the journey to complete this mission that
will help women with non-tubal ectopic pregnancy all over the world.
Julio Elito Jr.
Associate Professor of the Department of Obstetrics at Federal 
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Non-tubal ectopic pregnancies represent 7–10% of all ectopic pregnancies [1]. 
The incidence is increasing in the past years especially because of assisted reproduc-
tion treatment, particularly IVF, and the high rates of cesarean sections [2].
Non-tubal locations of ectopic pregnancies are cervix, cesarean section scar, 
interstitial portion of the fallopian tube, cornual, ovary, abdominal cavity, and 
broad ligament (Figure 1).
There is a broad spectrum of clinical presentation according to the location of 
the pregnancy. The first symptoms are pelvic pain and vaginal bleeding. In ruptured 
ectopic pregnancies, the patients present with severe abdominal pain, shoulder tip 
pain, nausea, vomiting and dizziness and collapse. However, some women with 
ectopic pregnancy are asymptomatic.
The diagnosis is usually late, because these pregnancies present themselves later 
than tubal pregnancies. Therefore, the risks of maternal morbidity and mortality 
are higher than in tubal ectopic pregnancies.
The management of non-tubal ectopic pregnancy depends on their location. The 
cases of abdominal pregnancy must be individualized and the treatment is different 
from the other sites of ectopic pregnancy. The diagnosis of ovarian pregnancy is 
usually confirmed only during the surgery.
The other sites (cesarean scar, cervical and intersticial pregnancy) follow a 
similar non-surgical protocol.
The classic treatment is surgery; however, it is very aggressive, because in the 
majority of the cases it is necessary to perform a hysterectomy. Several minimally 
invasive techniques have been proposed to avoid the mutilation of the uterus. Some 
of the alternative treatments to avoid surgery are local injection of MTX guided by 
transvaginal ultrasound, systemic medical treatment with methotrexate (MTX), 
and embolization of uterine arteries. There are several case reports in this subject 
but very few original articles. And in the few articles, there is no consensus on the 
best treatment. This book aims to provide the reader with a concise, comprehensive, 
and updated review of the epidemiology, diagnosis, and treatment of non-tubal 
ectopic pregnancy. As there is a lack of consensus on the guideline for the treatment 
of non-tubal ectopic pregnancy, this book intends to fill this gap in the literature, 
compiling the best evidences in the medical literature guiding the reader on choos-
ing the adequate treatment. An overview of each non-tubal ectopic pregnancy site 
will be presented in this introductory chapter.
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It represents 3% of ectopic pregnancies [3]. The sonographic aspect of ovarian 
pregnancy may range from gestational sac containing embryonic structures to 
solid and complex masses similar to those of tubal pregnancy. The major diagnosis 
difficulty is due to the fact that the pregnancy develops in the intimacy of the ovar-
ian parenchyma, losing the reference used in tubal pregnancy, which is to identify 
the ovaries and then look for the pelvic mass. In the case of tubal pregnancy, it 
is imperative to demonstrate the ipsilateral ovary, as well as the adnexal mass, in 
order to decrease the possibility of false-positive diagnosis with ovarian masses. 
Therefore, ultrasound in this eventuality is not specific, once it may confuse ovar-
ian pregnancy with other ovarian tumors. If gestational sac characteristics with 
embryonic structures are observed in the ovary, the diagnosis can be made with 
great precision [4].
Due to the difficulty of confirming the diagnosis noninvasively, most of the 
time, it is made during the intraoperative period. Thus, MTX treatment is used 
sporadically.
3. Intraligamentary abdominal pregnancy
Intraligamentary abdominal pregnancy is a rare form of ectopic pregnancy 
with a reported incidence of less than one in 250 ectopic pregnancies [5]. It usually 
results from the trophoblastic penetration of a tubal pregnancy through the serosa 
into the mesosalpinx, with secondary implantation between the leaves of the broad 
ligament. The placenta usually invades the intraligament space, ovary, uterus, 
omentum, pelvic peritoneum, and adjacent viscera [6].
Signs that may suggest intraligamentary abdominal pregnancy are abnormal 
vaginal bleeding, abdominal pain, painful fetal movements, easy palpation of the 
fetal parts, excessive nausea and vomiting, evidence of intrauterine growth restric-
tion, and oligoamnios. The main antenatal complications include abdominal pain, 
gestational sac rupture with hemorrhage to the peritoneal cavity, vaginal bleeding, 
anomalous presentation, placental insufficiency, and fetal death.
During surgery, the placenta should preferably be removed to reduce the risk of 
peritonitis, abscess, disseminated intravascular coagulation, and persistent tropho-
blastic disease.
Figure 1. 
Principal sites of ectopic pregnancy.
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Intraligamentary pregnancy is a condition of high maternal morbidity and mor-
tality, and a judicious preoperative evaluation and surgical technique are imperative 
for a favorable outcome.
4. Abdominal pregnancy
It constitutes of about 1.5% of ectopic pregnancies [7]. It represents a risk of 
maternal death 7.7 times higher than that of tubal pregnancy and 90 times higher 
than that of intrauterine pregnancy [8]. The blastocyst can be implanted anywhere 
in the abdomen and in the different organs covered by the visceral peritoneum. 
Thus, in abdominal pregnancy, there is the development of the pregnancy in the 
peritoneal cavity. It can be classified into primary or secondary. Primary abdominal 
pregnancy is rare; most are secondary due to tubal rupture or tubal abortion. Few 
fetuses survive in the abdominal cavity and advance beyond the second trimester of 
pregnancy. The diagnostic and therapeutic difficulties are remarkable regardless of 
the location of advanced abdominal pregnancy.
The most frequent ultrasound findings in abdominal pregnancy are as 
follows [9]:
• Uterus separated from fetus (90%)
• Extrauterine placenta (75%)
• Oligoamnium (45%)
• Fetal parts near the abdominal wall (25%)
• Absence of myometrium between fetus/placenta and bladder (15%)
• Anomalous fetal presentation (25–70%)
• Difficulty viewing the placenta (25%)
• Maternal intestinal loops obscuring fetal visualization (25%)
• Fetal anomalies (20–40%)
• Restricted intrauterine growth
• Lack of communication between endocervical canal and gestational sac
The most important signs are overlooked by the examiner because some unusual 
findings do not draw the examiner’s attention to the diagnosis of abdominal preg-
nancy. For example, uterine walls should be visualized even if attention is focused 
entirely on fetal evaluation, as myometrial tissue may not be identified. Given the 
clinical suspicion of abdominal pregnancy (the mother reports feeling the child 
superficially in the abdomen), ultrasound becomes mandatory, but will not always 
be able to confirm the diagnosis accurately. Magnetic resonance imaging can 
confirm the diagnosis.
Fetal survival in abdominal pregnancy is the exception rather than the rule, and 
the live-born fetus is often malformed. As conditions for the concept are precarious, 
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from 85 to 95% and maternal mortality is around 3% [10]. Anomalies occur in 
about 1/3 to 1/4 of the fetuses whose viability is possible.
As pregnancy progresses, the placenta develops in any portion or organ of the 
abdominal cavity. We often observe digestive symptoms of subocclusion and exces-
sive abdominal pain to fetal movements. The superficiality of the fetus is clear on 
palpation, as well as the auscultation of the fetal heartbeat. Ultrasound may demon-
strate that the uterus is empty and compressed by the fetus and placenta.
As fetal survival is the exception, many advise against hospitalization to await 
the viability of the fetus. In addition, the risk of life-threatening bleeding is high.
In cases of late diagnosis and with the fetus alive, the follow-up may be to wait 
until the 36th week. In the presence of a dead fetus or living fetus after the 36th 
week, laparotomy is required. Antenatal diagnosis of abdominal pregnancy is 
essential for proper planning of the procedure. Precise placement of the placenta 
can be done more accurately by magnetic resonance imaging (MRI). Preoperative 
care should be individualized for each case according to its severity. Interventional 
radiology can be used with the placement of balloon catheters to prevent signifi-
cant bleeding during surgery. In cases of dead fetus, selective embolization of the 
placental vessels may be performed. In addition, a multiprofessional staff may be 
required to perform insertion of ureteral catheters (double J), bowel preparation or 
transfusion blood reserve. An appreciable volume of blood and catheterized veins 
should be available to allow large volume to be infused rapidly, as well as a central 
venous pressure control and diuresis. In surgery, once the fetus is removed, the 
placenta is observed and, in particular, the site of its implantation. In cases where 
the placenta is attached to large vessels and the diagnosis is only made during sur-
gery, the placenta could be left to prevent massive bleeding and the cord removed 
very close to its implantation site. This attempt should be considered to transfer 
the patient to a tertiary hospital. Evidently, there is a possibility of complications, 
infection, abscess formation, bruising, and intestinal obstruction.
5. Interstitial pregnancy
Interstitial pregnancy is defined as an ectopic pregnancy that is implanted 
in the interstitial portion of the fallopian tube. The interstitial portion is thick, 
0.1–0.7 mm in diameter and 1–2 cm in length, and this part of the tube has a 
greater capacity to expand before rupture than the other segments of the tube 
[11]. Therefore, some cases are asymptomatic until the end of the first trimester of 
gestation and rupture may occur resulting in severe hemorrhage [12]. Because of 
the rich vascular anastomosis of the uterine and the ovarian arteries in this region, 
there may be accentuated hemorrhage. For this reason, early diagnosis is essential to 
reduce morbidity and mortality.
Interstitial pregnancies account for only 2–4% of ectopic pregnancies. However, 
the mortality rate is 2.5% [13]. This is because of the difficulty to confirm the 
diagnosis. Therefore, the late presentation could result in rupture and hemorrhage.
Interstitial pregnancy sometimes is incorrectly confused with cornual. Cornual 
pregnancy refers to a pregnancy in a horn of a bicornuate uterus or a rudimentary 
noncommunicating cavity horn or other Mullerian anomalies. The clinical outcome 
of cornual pregnancy varies greatly, depending on the size and expansile nature of 
the affected horn.
Risk factors for interstitial pregnancy are previous ectopic pregnancy, previous 
ipsilateral or bilateral salpingectomy, conception after in vitro fertilization, and 
history of sexually transmitted disease [14]. The symptoms of interstitial pregnancy 
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are pelvic pain and vaginal bleeding in the first trimester of pregnancy. On physical 
examination, an asymmetric uterine enlargement may be palpable. Signs of acute 
abdomen may occur in interstitial pregnancy rupture with hemoperitoneum; in 
some cases, tachycardia and hypotension may be present.
The following are the ultrasound features for the diagnosis of interstitial preg-
nancy are (Figure 2):
• Interstitial line (echogenic line between the gestational sac in the interstitial 
region and the endometrial cavity)
• Eccentrically located gestational sac and myometrial thickness less than 5 mm
It is important to point out that some viable intrauterine pregnancies are visual-
ized by ultrasound in its early stages, in one of the lateral angles of the uterine 
cavity, medial to the uterotubal junction. This situation usually evolves to a viable 
intrauterine pregnancy and in some cases the incorrect diagnosis could lead to an 
unnecessary pregnancy interruption.
Classical treatments for interstitial pregnancy are resection of the interstitial 
portion of the tube or hysterectomy. If the diagnosis is made before rupture, mini-
mally invasive surgery and nonsurgical treatment options can be used. Conservative 
options include methotrexate administration (local and systemic), expectant 
management, and minimally invasive surgical techniques that include resection of 
the involved interstitial portion of the tube and preserving the uterine architecture. 
The potential advantage of clinical treatment is to avoid a surgical scar on the uterus 
and the risks associated to surgery.
Expectant management that has been practiced based on the natural course of 
many early EPs is a self-limiting process [16]. The patients selection for this man-
agement are hemodynamically stable patients, beta-hCG ≤ 2000 mUI/ml, decline 
Figure 2. 
Interstitial ectopic pregnancy: Presence of an eccentric gestational sac with myometrial tissue that surrounds the 
gestational sac with a thickness of 2 mm and the interstitial line [15].
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are pelvic pain and vaginal bleeding in the first trimester of pregnancy. On physical 
examination, an asymmetric uterine enlargement may be palpable. Signs of acute 
abdomen may occur in interstitial pregnancy rupture with hemoperitoneum; in 
some cases, tachycardia and hypotension may be present.
The following are the ultrasound features for the diagnosis of interstitial preg-
nancy are (Figure 2):
• Interstitial line (echogenic line between the gestational sac in the interstitial 
region and the endometrial cavity)
• Eccentrically located gestational sac and myometrial thickness less than 5 mm
It is important to point out that some viable intrauterine pregnancies are visual-
ized by ultrasound in its early stages, in one of the lateral angles of the uterine 
cavity, medial to the uterotubal junction. This situation usually evolves to a viable 
intrauterine pregnancy and in some cases the incorrect diagnosis could lead to an 
unnecessary pregnancy interruption.
Classical treatments for interstitial pregnancy are resection of the interstitial 
portion of the tube or hysterectomy. If the diagnosis is made before rupture, mini-
mally invasive surgery and nonsurgical treatment options can be used. Conservative 
options include methotrexate administration (local and systemic), expectant 
management, and minimally invasive surgical techniques that include resection of 
the involved interstitial portion of the tube and preserving the uterine architecture. 
The potential advantage of clinical treatment is to avoid a surgical scar on the uterus 
and the risks associated to surgery.
Expectant management that has been practiced based on the natural course of 
many early EPs is a self-limiting process [16]. The patients selection for this man-
agement are hemodynamically stable patients, beta-hCG ≤ 2000 mUI/ml, decline 
Figure 2. 
Interstitial ectopic pregnancy: Presence of an eccentric gestational sac with myometrial tissue that surrounds the 
gestational sac with a thickness of 2 mm and the interstitial line [15].
Non-tubal Ectopic Pregnancy
8
of the titers of beta-hCG in an interval of 24/48 h, and interstitial pregnancy 
mass ≤ 3.5 cm and without fetal cardiac activity.
Systemic methotrexate treatment was used for the first time in an interstitial 
pregnancy. In 1982, Tanaka et al. [17] successfully treated an interstitial pregnancy 
using methotrexate. Ectopic interstitial pregnancies without embryonic cardiac 
activity and beta-hCG ≤ 5000 mUI/ml should be treated using a single dose of 
MTX 50 mg/m2 IM. Cases with beta-hCG > 5000 mUI/ml should be treated with a 
protocol of multiple doses of MTX. On the other hand, cases with embryonic heart 
activity should be treated with transvaginal administration of MTX under sono-
graphic guidance.
6. Cervical pregnancy
Cervical ectopic pregnancy is defined by the implantation and development of 
the conceptus in the cervical canal. Among all ectopic pregnancies, the cervical 
pregnancy is the rarest, representing about 0.4% of cases [1]. It is accompanied 
by high morbidity and mortality, which can lead to severe hemorrhage, due to the 
rich vascularization of the cervix and a small amount of muscle fibers. The etiol-
ogy is not well established; however, some predisposing factors were related, such 
as previous uterine curettages and cesarean section, Asherman syndrome, history 
of uterine and cervical surgeries, and in vitro fertilization. The diagnosis is made 
through history and physical examination and confirmed by ultrasound. Patients 
with menstrual delay and positive pregnancy tests may be asymptomatic, complain 
of vaginal bleeding, or even have severe vaginal bleeding. On vaginal examination, 
the cervix will be enlarged and congested, with painful tumoration. In addition, 
however, complaints and physical examination are often nonspecific, making clini-
cal diagnosis difficult.
Early diagnosis made by ultrasound contributes to the success of conservative 
therapies. Ultrasound findings include empty uterine cavity; endometrial decidu-
ous reaction; hourglass-shaped uterus; enlarged cervical canal; gestational sac 
within the canal, with or without heartbeat; placental tissue surrounding the gesta-
tional sac; and closed internal os of the cervix. These findings can also be visualized 
in MRI with more accuracy (Figure 3).
If the clinical condition is unstable due to the hemorrhagic situation, it is valid 
to use the Foley catheter into the cervix insufflating from 30 to 100 ml while the 
patient is stabilized and then to evaluate the need for a hysterectomy.
With the development of conservative treatment protocols, the need for hys-
terectomies has decreased from 89.5% before 1987 to 21% in 1994. Conservative 
treatment options can be categorized as tamponade, which is performed with 
intracervical balloon after curettage; cerclage to reduce cervical artery blood flow 
associated with manual intrauterine cervical aspiration; reduced blood supply 
through embolization or uterine artery ligation; excision of trophoblastic tissue by 
hysteroscopic resection; intra-amniotic feticide, by local injection of methotrexate; 
and systemic chemotherapy with intramuscular methotrexate.
In cases of embryo without heartbeat with high beta-hCG titers, multiple dose 
of systemic MTX treatment is the preferred therapeutic option. When the embryo 
presents heartbeat, local treatment with MTX is indicated. Elito et al. [18] pub-
lished a series of eight cases of cervical pregnancy with live embryo treated with 
transvaginal US-guided gestational sac puncture and MTX injection (1 mg/kg). All 
patients were successfully treated. The initial beta-hCG ranged from 3013 to 71,199 
mIU/mL. Only one case evolved to infection. There was no need for further inter-
ventions in this case series. The time interval for beta-hCG titers to be negative was 
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2–12 weeks. The period for the disappearance of the image of the ectopic pregnancy 
assessed by ultrasound was 3–14 weeks. Two patients had subsequent intrauterine 
pregnancies. The authors concluded that conservative treatment of cervical ectopic 
pregnancy with live embryos treated with transvaginal US-guided puncture and 
MTX injection is effective and avoids other mutilating interventions.
7. Cesarean scar pregnancy
Pregnancy in cesarean section scar is the rarest form of ectopic pregnancy. 
From the first case described in 1978 [19] to 2001, there were only 19 reported cases 
[20]. In 2006, there were 155 cases and in 2011 the number of cases described in 
the literature was 751, which shows a rapid increase in the incidence of this type 
of pregnancy. The estimated incidence is from 1 in 1800 to 1 in 2216 pregnancies, 
with a rate of 6.1% of all ectopic pregnancies in women with a history of previous 
cesarean section [1].
The basis of the pathophysiology is the invasion of the blastocyst in the myome-
trium through minimal communication between the anterior cesarean section scar 
and the endometrial cavity.
Risk factors are previous cesarean sections, short time between cesarean section 
and current pregnancy, IVF treatment, and retroverted uterus, which may lead to 
greater cesarean section scar dehiscence increasing the chance of implantation of 
the gestational sac in this region.
The cesarean scar ectopic pregnancy tends to behave more aggressively because 
of the risk of uterine rupture and bleeding in the first and second trimesters of 
pregnancy.
Transvaginal ultrasound allows early diagnosis of the disease before these tragic 
outcomes and allows conservative treatment rather than mutilating surgeries such 
as hysterectomy and then preserving fertility. It also allows differential diagnosis 
with ongoing abortion, molar pregnancy, and ectopic cervical pregnancy.
The diagnosis can be made by ultrasonography (Figure 4) and magnetic reso-
nance imaging (Figure 5).
Transvaginal ultrasound findings for cesarean scar pregnancy include empty 
uterine cavity, decidual reaction, trophoblast located at the site of previous cesarean 
scar, and absence of healthy myometrium between the bladder and gestational sac.
Figure 3. 
Magnetic resonance image showing cervical pregnancy, hourglass-shaped uterus, empty uterine cavity, and 
cervix with heterogeneous mass inside. (author image file).
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There are two types of ectopic pregnancy in cesarean scar section: endogenous 
and exogenous. In the endogenous type, gestational sac implantation occurs in 
the cesarean section scar, with the development of pregnancy toward the uterine 
cavity. The exogenous type occurs with deeper implantation of the gestational sac 
in the cesarean scar, and as the pregnancy develops in the direction of the bladder, it 
increases the risk of rupture and hemorrhage in the first trimester of pregnancy.
The relationship between the gestational sac of a cesarean scar pregnancy and 
the endometrial line is defined as crossover sign (COS). In this sonographic sign, a 
straight line was drawn connecting the internal cervical os and the uterine fundus 
through the endometrium (endometrial line). The gestational sac was identified 
and its diameter, perpendicular to the endometrial line, was traced. Patients were 
categorized according to the relationship between the endometrial line and the 
diameter of the gestational sac into two groups: (1) COS-1, in which the gestational 
sac was implanted within the cesarean scar, and at least two-thirds of the diameter of 
the gestational sac was above the endometrial line, toward the anterior uterine wall; 
and (2) COS-2, in which the gestational sac was implanted within the cesarean scar, 
and less than two-thirds of the gestational sac was above the endometrial line [21] 
(Figure 6).
Figure 4. 
Cesarean scar pregnancy in the isthmic region with the presence of gestational sac with embryo. (author image 
file).
Figure 5. 
MRI of the uterus demonstrating an empty uterus, an empty cervical canal, the gestational sac being located in 
the anterior part of the isthmic portion of the uterus with a diminished myometrial layer, and a discontinuity 
in the anterior wall of the uterus.
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This crossover sign may help to determine whether a cesarean scar pregnancy 
will progress to rupture in the first trimester (COS-1), or in a COS-2 case, the 
pregnancy could continue running the risk of placenta accreta and cesarean hyster-
ectomy [21].
Approaches are divided into surgical and nonsurgical treatment. Surgical treat-
ment may include uterine curettage or hysterectomy and uterine artery emboliza-
tion. Nonsurgical treatment may be expectant or medical treatment with systemic 
or local methotrexate.
There is still no consensus on the best mode of treatment in case of ectopic 
pregnancy in cesarean scar section.
Surgical intervention is performed in the presence of important bleeding and, 
under these circumstances, if possible, a uterine artery embolization attempted 
before curettage or hysterectomy.
Dilatation and curettage with subsequent intrauterine Foley catheter insertion 
may be an option due to the simplicity. However, the risk of this treatment is the 
hemorrhage and the necessity of secondary hysterectomy. This treatment should 
only be used in selected cases.
Excision by hysteroscopy is another option. During the procedure, the pelvic 
ultrasound could help to avoid complications.
Excision by laparotomy or laparoscopy could be attempted. These procedures 
usually are performed if local MTX treatment failed or after uterine rupture.
Hysterectomy is usually performed when other treatments failed and to con-
trol the bleeding (Figure 7). This procedure is not the first line for the majority of 
gynecologists.
When the patient presents a cesarean scar pregnancy COS-2 or endogenous 
type and it is a viable pregnancy, the patient should be advised about the risks 
of continuing with the pregnancy. The late diagnosis of cesarean scar pregnancy 
evolves to a placenta accreta. The risks of continuing the pregnancy are hemor-
rhage (13% in first and second trimesters, and 39% in third trimester), uterine 
rupture (9.9% in first and second trimesters, and 10.2% in third trimester), 
placenta accreta 75%, and hysterectomy (15.2% in first and second trimesters, 
and 60.6% in the third trimester) [22]. The physician should discuss these risks 
and advise the patient. A deep reflection of the situation is required before 
taking the decision to keep or not the pregnancy, once the couple usually already 
has one child. When the decision is to continue with the pregnancy, some criteria 
Figure 6. 
Crossover sign representing COS 1, in which the gestational sac was implanted within the Cesarean scar, and 
at least two-thirds of the diameter of the gestational sac was above the endometrial line, towards the anterior 
uterine wall; and COS-2, in which the gestational sac was implanted within the Cesarean scar, and less than 
two-thirds of the gestational sac was above the endometrial line [21].
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should be evaluated. In cases that have crossover sign (COS-1) or exogenous type 
and the magnetic resonance shows myometrium less than 5 mm, the pregnancy 
should be interrupted. In the other situation COS-2 or endogenous type and 
myometrium thickness > 5 mm, if the patient opts to continue with the preg-
nancy, they should be advised about the risk of placenta accreta and cesarean 
hysterectomy and should be assisted in a hospital with interventionist radiology 
and neonatal intensive care.
Systemic methotrexate treatment is not effective in cases where the embryo has 
heartbeat. This treatment should be avoided in this condition because it delays a 
more effective treatment.
In cesarean scar pregnancy when the embryo/fetus has heartbeat, local metho-
trexate (1 mg/kg) treatment guided by transvaginal ultrasound should be the first 
option [23] (Figures 8 and 9). The current scientific evidences demonstrate that 
local treatment with MTX brings best results. This type of treatment is broadly used 
because it is not only effective but also simple and low cost.
In cases where the embryo/fetus has no heartbeat, it is important to check the 
titers of beta-hCG in an interval of 24/48 hours. If the levels were low and declin-
ing, the best approach is the expectant management. However, if the titers were 
high and increasing, the patient should be submitted to the systemic treatment with 
MTX. If the levels of beta-hCG are low (less than 5.000 mUI/ml), a single dose 
of MTX 50 mg/m2 (same treatment of tubal pregnancy) is recommended. On the 
other hand, if the levels are higher (>5.000 mUI/ml), a protocol of multiple doses 
of MTX (1 mg/kg) on days 1, 3, 5, and 7 and folinic acid (0.1 mg/kg) on days 2, 4, 6, 
and 8 is recommended.
The MTX treatment is an outpatient follow-up with weekly examinations of 
β-hCG until resolution. During outpatient follow-up, ultrasound is not routinely 
performed and should only be repeated when β-hCG reaches a negative value 
3 months in a row. Other than that the ultrasound should be repeated during the 
treatment in any case of complication suspected. In general, after 3–6 months, 
the image of the ectopic pregnancy disappears, and at this point, it is recom-
mended to perform hysterosalpingography and hysteroscopy for a better evalua-
tion of the uterine cavity, as well as appropriate reproductive planning for these 
patients [1].
In cases where the resolution takes a long period, other treatments could be 
offered, such as gestational sac aspiration under ultrasound or hysteroscopy to 
remove the gestational tissue with vascular coagulation of the implantation site.
Figure 7. 
Case of cesarean scar pregnancy evolved to hemorrhage and the patient was submitted to hysterectomy.
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In cases where local methotrexate treatment fails, uterine artery embolization 
should be considered [24], or laparoscopic or laparotomic cesarean scar pregnancy 
wedge resection with subsequent surgical correction of the cesarean section scar.
Birch et al. [25] in a systematic review about treatments for cesarean scar preg-
nancy showed that uterine artery embolization (UAE) combined with D&C had 
good results, because it presented a low risk of heavy bleeding and hysterectomy.
Figure 8. 
The patient in the lithotomy position. A 22-gauge, 15 cm Wallace needle was inserted via vaginal route under 
transvaginal ultrasound guidance.
Figure 9. 
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The UAE procedure can be performed under spinal anesthesia and conscious seda-
tion with standard antibiotic prophylaxis. After asepsis of groin area, the right or left 
common femoral artery is cannulated via the Seldinger technique, introducer 5F, and 
the procedure continues such as in the uterine fibroid embolization, with catheteriza-
tion of the left uterine artery and subsequently the right uterine artery. Methotrexate 
is injected transarterially prior to the embolization with occluding microparticles, 
always larger than 500 μ to avoid paradoxical embolization to the ovary [26] 
(Figure 10). Despite arterial occlusion, the risk of severe bleeding is non-negligible 
because of gradual restoration of the normal circulation within approximately 
3 weeks. The dilation and curettage with suction or vacuum aspiration 6–8 hours after 
intra-arterial chemoembolization reduce the incidence of bleeding [25].
Figure 11. 
The management protocol of cesarean scar pregnancy.
Figure 10. 
Bilateral uterine angiography before and after uterine artery embolization (a) uterine arteries were enlarged 
by means of hypervascular infusion of methotrexate before uterine artery embolization, (b) unilateral 
occlusion was successfully performed, (c) bilateral arterial occlusion was confirmed after the uterine artery 
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There is a lack of consensus on the guideline for the treatment of cesarean scar 
pregnancy and several options of treatment are proposed in the literature (isolated 
or combined) [27]. Therefore, the author prepared a protocol to manage cesarean 
scar pregnancy based on his experience and the scientific evidences collected until 
now (Figure 11).
8. Nonsurgical treatment in non-tubal pregnancies
Management in cases of interstitial, cervical, and cesarean scar pregnancy 
should always be individualized. Nonsurgical treatment has emerged as an 
important alternative for these situations, avoiding surgeries that compromise the 
reproductive future. When the embryo has heartbeat, USTV-guided local treatment 
with MTX injection into the gestational sac at a dose of 1 mg/kg is the first-line 
treatment. When beta-hCG titers are greater than 5000 mIU/ml, the local treatment 
is complemented with the systemic multiple-dose protocol starting the day after 
puncture. Systemic treatment with MTX is performed in cases where the embryo 
has no heartbeat. The medical treatment will depend on the initial beta-hCG titer. 
For titers below 5000 mIU/ml, a single dose of MTX 50 mg/m2 IM is recommended. 
On the other hand, if beta-hCG titers are greater than 5000 mIU/ml, a multiple 
dose MTX protocol is recommended. The MTX dose is 1 mg/kg IM on days 1, 3, 5, 
and 7, alternating with folinic acid at the dose of 0.1 mg/kg IM on days 2, 4, 6, and 8 
(Figure 12).
9. Final considerations
Non-tubal pregnancy is a challenge for obstetricians due to the maternal 
morbidity and mortality. The incidence is increasing and the physicians should be 
aware of this situation. The early diagnosis by ultrasound is essential for a minimal 
invasive treatment avoiding fertility loss. There are several options for the treatment 
and no consensus in medical literature. In this introductory chapter, surgical and 
nonsurgical approaches as well as guidelines have been presented for the treatment 
of non-tubal pregnancy based on current scientific evidence.
Figure 12. 
Nonsurgical protocol of non-tubal pregnancy.
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Non-tubal Ectopic Pregnancy: 
Incidence and Diagnosis
Aliye Nigar Serin and Özer Birge
Abstract
Ectopic pregnancies occur at 1–2% of all pregnancies. The most common 
implantation site is the fallopian tube with 95, and 5% are non-tubal located. The 
aim of this review is to determine the current state of data about the diagnosis and 
the treatment of non-tubal ectopic pregnancies. Literature is reviewed concern-
ing cervical, interstitial, cornual, ovarian, Caesarean scar, and abdominal ectopic 
pregnancies from PubMed databases. Non-tubal ectopic pregnancies are often mis-
diagnosed and overlooked. Clinical symptoms and ultrasound must be combinated 
to diagnose. Management may involve medical treatment with methotrexate or 
surgery or a combination according to patient’s clinical stability and the location of 
ectopic pregnancy. Non-tubal ectopic pregnancies are rare but can be a life-threat-
ening condition due to late diagnosis. Early diagnosis and treatment of patients are 
associated with decreased morbidity and mortality in non-tubal pregnancy and, 
very importantly, preserve the uterus and subsequent fertility. İncreased experi-
ences have led to choose the best way to manage non-tubal pregnancies and develop 
new techniques.
Keywords: non-tubal ectopic pregnancy, methotrexate, cervical, interstitial, cornual, 
ovarian, caesarean ectopic
1. Introduction
An ectopic pregnancy (EP) refers to the implantation of a pregnancy outside of 
the uterus cavity. The overall rate of EP is 1–2% in the general population and 2–5% 
among patients who have utilized assisted reproductive technology (ART) [1, 2]. 
Up to 98% of ectopic pregnancies occur in the fallopian tubes. Non-tubal ectopic 
pregnancies are rare, accounting for 7–10% of all ectopic pregnancies and occur-
ring outside the uterus and tubes [3, 4], yet are associated with higher morbidity 
due to their late presentation and diagnostic difficulties [5–8]. There are six main 
locations for non-tubal ectopic pregnancies that are cervical, interstitial, cornual, 
ovarian, Cesarean scar, and abdominal. The main risk factors for non-tubal preg-
nancy include previous ectopic, history of assisted reproduction, pelvic infections, 
smoking, and the use of the progesterone only pill or intrauterine device [9]. Early 
diagnosis and treatment of patients are associated with decreased morbidity and 




2. Cervical ectopic pregnancy
Cervical pregnancies are rare accounting for less than 1% of all ectopic pregnan-
cies, and the incidence is 1:2500–18,000 [3, 4, 9]. They result due to the risk of 
trophoblast penetration through the mucosa of cervical wall into the uterine vessels. 
Cervical ectopics may arise should the blastocyst pass through the uterine cavity 
and implant into the mucosa of the endocervical canal [10–13]. Almost 70% of 
cases with subsequent cervical EP have a history of dilation and curettage (D&C) 
in a previous pregnancy [12, 14]. Also in vitro fertilization (IVF) seems as a risk 
factor but often jointly with D&C and other possible risk factors; anatomic anoma-
lies (myomas, synechiae), intrauterine device (IUD) use, and diethylstilbestrol 
exposure, although these are not strong associations, are difficult to isolate as an 
independent contributor to risk [15].
Vaginal bleeding without pain is the most common presenting symptom but 
in more advanced pregnancies may be coupled with abdominal pain and urinary 
problems. Examination findings include an enlarged, globular, or distended cervix, 
which is often associated with dilatation of the external os [12].
Before 1979, cervical pregnancy was almost always associated with hysterectomy 
because of out-of-control vaginal bleeding, and the primary diagnosis was made by 
histological analysis of the hysterectomized uterus [16]. Preoperative diagnosis was 
rarely possible. After the first ultrasound report of cervical pregnancy was published 
by Raskin in 1978, transvaginal ultrasonography has become the main diagnostic tool 
[17]. This put forward more conservative approaches that attempt to limit morbidity 
and preserve fertility. The majority of patients with a cervical pregnancy are women 
with low parity; thus, preservation of reproductive function is a priority [12].
Cervical pregnancy may appear as a hemorrhagic mass, gestational sac, or presence 
of a fetus (with or without cardiac activity) on TvUSG [10, 12]. Defined sonographic 
criteria are shown in Table 1. A cervical EP is identified on ultrasound by a distended 
cervical canal containing a gestational sac (Figure 1), below a closed internal cervical 
os [19, 20], misdiagnosed as an intrauterine pregnancy with a low implantation site or 
a failed pregnancy imminent abortion. The “sliding sign” involves the sliding of the 
products of conception against the endocervical canal when gentle pressure by the 
sonographer during transvaginal ultrasound associated with spontaneous abortions in 
progress and should be absent in a cervical ectopic pregnancy [5, 6, 9].
The treatment for cervical ectopic pregnancy is unclear. İf gestation is 
<12 weeks, with no fetal heart present and lower-serum hCG values, conservative 
management is most effective in women wishing to preserve fertility [21, 22].
Single- or multiple-dose systemic methotrexate (MTX) efficacy is 91%, reported 
in a meta-analysis [21]. MTX is more successful in pregnancies <9 weeks and with 
beta hCG levels <10,000 mIU/mL, CRL <10 mm, and absent fetal cardiac activity 
[9, 23]. The folic acid antagonist methotrexate is the most widely used systemic 
chemotherapy.
Table 1. 
Sonagraphic criteria for cervical pregnancy.
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In cervical pregnancy with embryonic heart activity, the treatment of choice is 
local injection of methotrexate or potassium chloride by ultrasound-guided injec-
tion [24].
İn the treatment of cervical ectopic pregnancy, uterine artery ligation, uterine 
artery embolization, balloon tamponade, cervical curettage, cerclage, cervical stay 
sutures, and injection of prostaglandin F2a can be combined to control hemorrhage 
[3, 7, 10, 25].
Medical management must only be suggested if the patient is hemodynamically 
stable; otherwise, surgical treatment should be attempted as dilatation and evacua-
tion, hysteroscopic resection, and hysterectomy.
3. Interstitial ectopic pregnancy
The incidence of interstitial pregnancy is 1–11% of all ectopic pregnancies. 
It has a high complication and maternal mortality rate, approximately 20% 
of all deaths caused by ectopic pregnancies [3–5]. The pregnancy implants at 
the junction of the interstitial part of the fallopian tube and the uterine myo-
metrium. The main risk factor for interstitial implantation is prior ipsilateral 
salpingectomy; a residual “stump” of tube may form the focus of ectopic preg-
nancy development [26]. Symptoms are amenorrhea or spotting with or without 
abdominal pain.
Diagnostic criteria by ultrasound include:
1. Myometrial tissue <5 mm thick surrounded by gestational sac [26] (Figure 2).
2. An echogenic line between the gestational sac in the cornua and endometrial 
cavity named “interstitial line” has a sensitivity of 80% and specificity of 98% 
[4–6, 28] (Figure 3).
3. Empty uterine cavity and gestational sac located in the interstitial portion of 
the tube, >1 cm far away from cavity [4, 6, 29].
Conservative management may be appropriate in patients who are hemodynam-
ically stable without rupture and with a low or falling beta hCG but carries a risk 
Figure 1. 
Cervical ectopic pregnancy [18].
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of uterine rupture due to the weakened myometrial wall [4]. Medical management 
is to use of methotrexate either given systemically or by local injections. Single- or 
multiple-dose methotrexate regimens have success rates between 66 and 100% [9]. 
There is risk of failure due to increased vascularity, higher beta hCGs, and larger 
gestational sacs, so patient selection must be critical. Using systemic methotrexate 
in combination with gefitinib (oral epidermal growth factor receptor inhibitor) 
may be an alternative therapy [30].
Surgical treatment is indicated when medical management failure, according to 
patient preference, or if there is hemodynamic instability, severe hemorrhage, and/
or findings concerning rupture, including pain or imaging evidence of hemoperito-
neum. Minimally invasive surgeries are cornuostomy, salpingostomy, and cornual 
resection for earlier diagnosis. Cornuostomy (entails a linear incision, following 
the injection of dilute vasopressin at the cornua to minimize blood loss), cornual 
resection, or salpingostomy is being used for smaller interstitial ectopic pregnancies 
measuring <3.5 cm [31, 32]. Cornual resection has been recommended for advanced 
management of more interstitial pregnancies >3.5 cm [33, 34]. Laparotomy and 
hysterectomy are still the first-line treatment in patients with hemodynamic insta-
bility and severe hemorrhage. Selective uterine artery embolization can be used in 
Figure 2. 
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conjunction with methotrexate in order to reduce hemorrhage, but there are concerns 
about the safety and complications of future pregnancies after this technique [35, 36].
4. Cornual ectopic pregnancy
Cornual pregnancies are one of the rare forms of ectopic pregnancy at 0.2–2% 
and occur in a cornua of a bicornuate uterus, in an rudimentary horn, in a unicor-
nuate uterus, and/or in a septate uterus [37]. Cornual and interstitial pregnancies 
are often referred to interchangeably, but the following criteria can be used to 
diagnose cornual pregnancy on ultrasound examination [38]:
1. A single interstitial portion of fallopian tube in the main uterine body.
2. A mobile gestational sac surrounded by myometrium and separate from the 
uterus.
3. Gestational sac adjoining to the unicornuate uterus with a vascular pedicle.
Methotrexate is generally ineffective due to late diagnosis. Surgery is the main 
management for cornual ectopic pregnancies that includes myomectomy for an 
unruptured ectopic, laparoscopic cornuotomy, cornual resection, or excision of the 
rudimentary horn [4, 39–41]. Laparotomy and hysterectomy may prove necessary 
due to hemorrhage or large cornual ectopics. Elective Cesarean section is widely 
recommended in subsequent pregnancies because of risk of uterine rupture.
5. Ovarian ectopic pregnancy
Ovarian ectopic pregnancy accounts for 3% of all ectopic pregnancies [42]. 
Previous pelvic inflammatory disease, endometriosis, and assisted reproductive 
technologies seem as risk factors [43–47]. İnterference in the release of the ovum 
from the ruptured follicle, tubal malfunction, and inflammatory thickening of the 
tunica albuginea are suggested etiologies [48]; however, ovarian ectopic pregnan-
cies have been reported in patients lacking fallopian tubes [49]. Usually symptoms 
present with abdominal pain and light vaginal spotting. Diagnosis can be difficult to 
differentiate from a hemorrhagic or corpus luteal cyst or indeed a tubal ectopic.
Diagnostic criteria described by Spiegelberg [50] (Figure 4):
1. Completely intact fallopian tubes.
2. Anatomically gestational sac located in the normal position at the ovary.
3. Both ovary and gestational sac connected to the uterus by ovarian ligament.
4. Placental trophoblastic tissue attached to the ovarian cortex.
Also ovarian EPs may be suspected by ultrasound when a hypoechogenic area 
is seen with peripheral Doppler flow surrounded by a wide echogenic ring and 
may be completely surrounded by ovarian cortex, and a fetal pole is rarely present 
[38, 43].
Management is most commonly surgical, and little data is available on the 
medical management of this condition with systemic MTX either single- or 
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multiple-dose regimens [2]. Fifty milligrams of MTX injections directly into the 
ovarian EP with transvaginal or laparoscopically have also been reported as a suc-
cessful management [52, 53]. MTX may also be used in the treatment of persistent 
trophoblastic tissue after laparoscopy [45]. Partial or total oophorectomy or ovarian 
wedge resection with laparoscopic surgery has become the standard for manage-
ment of hemodynamically stable patients [7, 9]. Conservative resection (wedge 
resection) is performed in patients who want to preserve their fertility.
6. Abdominal ectopic pregnancy
The rarest form of ectopic pregnancies is at 0.9–1.4% and relates to implanta-
tion at sites throughout the abdomen including omentum; organs such as the liver, 
spleen, and bowel; large vessels; pelvic cul-de-sac; broad ligament; and pelvic side 
wall [4, 28, 54–56]. Abdominal ectopic pregnancy can be defined as primary or 
secondary; when the fimbrial end does not ‘pick up’ the ovulated follicle is primary 
type, tubal abortion via the fimbria and peritoneal implantation related with 
secondary abdominal ectopics [4, 28]. Risk factors are similar to tubal ectopic prior 
history of a medically treated ectopic, previous pelvic inflammatory disease, prior 
surgery, endometriosis, and assisted conception. Abdominal ectopic pregnancies 
have been described after ART, specifically after IUI [57], after IVF [58], and after 
Clomid [59]. Symptoms include abdominal pain, painful fetal movements, vagi-
nal bleeding, nausea, and vomiting. Abdominal X-ray, ultrasound, or diagnostic 
laparoscopy are used to diagnose, although MRI may be beneficial. İn several case 
reports, diagnosis is only made at Cesarean section [60].
Diagnostic ultrasound criteria have been suggested by Gerli et al. [61]:
1. Absence of an intrauterine gestation sac.
2. Absence of tube and a complex adnexal mass.
3. Gestational cavity surrounded by loops of bowel and separated by peritoneum.
4. Wide mobility similar to fluctuation of the sac with pressure of the transvagi-
nal probe toward the posterior cul-de-sac.
Figure 4. 
Ovarian ectopic pregnancy [51].
27
Non-tubal Ectopic Pregnancy: Incidence and Diagnosis
DOI: http://dx.doi.org/10.5772/intechopen.87957
Laparotomy and delivery with removal of the fetus with or without placental 
tissue are the traditional management [62]. The maternal mortality rate is eight times 
higher than for any other ectopic pregnancies [63, 64]. Expectant management sug-
gested at rare reports orders to attain a live birth. If abdominal pregnancy is diagnosed 
after the twentieth week of gestation, expectant management can be considered with 
close follow-up at a tertiary health care facility. Delivery is recommended at 34 weeks 
if fetus has no congenital malformations, and placenta which implanted away from 
upper abdomen is often left in place to avoid the risk for hemorrhage [65, 66]. A few 
case reports have described subsequent methotrexate treatment and ultrasound-
guided injection of potassium chloride [4] or radiological artery embolization to 
minimize blood loss before leaving placental tissue behind [28, 56, 67–69].
7. Cesarean scar pregnancy
Cesarean scar pregnancies are extremely rare, 1:2226 of all pregnancies and 
6% of all ectopic pregnancies in women who have undergone at least one previous 
Cesarean section [4]. Scar pregnancies may be presented with painless vaginal 
bleeding and also associated with significant rates of uterine rupture and major 
hemorrhage, uterine rupture, and hypovolemic shock [50]. Risk factors include 
previous Cesarean, myomectomy, dilatation and curettage, adenomyosis, IVF, and 
manual removal of the placenta [28, 70]. The suggested theory of pathogenesis 
is the blastocyst enters a microscopic tract in the uterine scar and implants in the 
deficient uterine wall. The impact of the number of previous Cesarean sections, 
the time interval between Cesarean sections, and the rate of scar implantation are 
unclear [71–73]. With increasing rates of Cesarean section and repeated Cesarean 
sections, the scar surface area is getting bigger and is increasingly deficient due 
to fibrosis, poor vascularity, and postoperative healing, thereby leading to higher 
rates of blastocyst implantation [72]. Although it is suggested to use ultrasound 
with Doppler, hysteroscopy, and MRI to diagnose and differentiate Cesarean 
scar from cervical ectopic pregnancies, transvaginal ultrasound is the first-line 
approach [50].
Ultrasound diagnostic criteria by Jurkovic et al. [74]:
1. An empty uterine cavity without contact with the sac.
2. Gestational sac located anteriorly at the level of the internal os covering the 
visible or presumed site of the previous lower uterine segment of the prior 
hysterotomy (Figure 5).
3. The myometrium must be very thin (1–3 mm) or absent between the bladder 
and sac (Figure 6).
4. A negative “sliding organ sign” and the presence of peripheral Doppler flow.
There is no definitive consensus of treatment, yet first-trimester termination is 
recommended to prevent uterine rupture, major hemorrhage, life-threatening com-
plications, and maternal morbidity and preserve future fertility. Term births are asso-
ciated with hemorrhage and emergent cesarean hysterectomy [74, 77, 78]. Systemic 
methotrexate can be used in hemodynamically stable patients with an unruptured 
scar pregnancy, <8 gestation weeks, and a myometrial thickness of <2 mm between 
the pregnancy and the bladder and more successful if beta hCG level is <5000 IU/L 
[74]. Local potassium chloride, bilateral uterine artery injection of methotrexate 
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combined with embolization, and combination of gefitinib and systemic methotrex-
ate have been described [4, 30]. Surgical approaches are uterine curettage, resection 
or excision with hysteroscopy, laparoscopy or laparotomy. Curettage is an accepted 
treatment under ultrasound guidance following chemotherapy, but it should not 
be performed as a first-line treatment because of complication with hemorrhage. 
Resection allows for revision of the lower uterine segment, which theoretically may 
reduce risk for recurrence [79]. Hysteroscopic resection is not recommended when 
the residual myometrium is less than 3 mm, given the risk of anterior wall perforation 
and bladder injury [80, 81]. Hysterectomy may be required for uterine rupture or 
more advanced pregnancies [4].
8. Conclusion
Non-tubal ectopic pregnancies are rare but can be a life-threatening condition 
due to late diagnosis. Earlier diagnosis and treatment of patients are associated with 
decreased morbidity and mortality in non-tubal pregnancy and, very importantly, 
preserve the uterus and subsequent fertility [28]. Clinicians should have a high 
index of suspicion in patients presenting with pain and bleeding in pregnancy and 
take careful note of their previous obstetric and gynecology history to identify key 
risk factors for ectopic pregnancy. Ultrasound criteria now exist for all non-tubal 
Figure 5. 
Caesarean scar pregnancy [75].
Figure 6. 
Myometrial thickness of scar pregnancy [76].
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ectopic pregnancies, facilitating early diagnosis and giving the patient options 
for management. It seems reasonable therefore to treat these pregnancies with a 
combination of local or systemic chemotherapy and/or surgical removal. Increased 
experiences have led to choose the best way to manage non-tubal pregnancies and 
develop new techniques.
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Non-tubal Ectopic Pregnancy: 
Diagnosis and Management
Adebayo A. Adeniyi and Christopher A. Enakpene
Abstract
Ectopic pregnancy is the leading cause of maternal mortality in the first 
trimester, and prompt diagnosis and intervention are essential to ameliorate 
its associated complications. A majority of ectopic pregnancies are tubal, but 
extra-tubal pregnancy may pose more challenges in diagnosis and treatment. 
Early diagnosis of extra-tubal pregnancies requires high index of suspicion using 
transvaginal ultrasound and at times complemented with the help of magnetic 
resonance imaging. Similar to tubal pregnancy, extra-tubal ectopic pregnancies 
can be treated using surgical approach via laparotomy versus laparoscopy, or 
medical intervention with methotrexate, potassium chloride and most recently, 
mifepristone and epidermal growth factor inhibitor (gefitinib). For abdominal 
and ovarian ectopic pregnancies, the best surgical approach is via laparotomy or 
laparoscopy, while for cervical ectopic pregnancy and cesarean scar pregnancy 
(CSP), initial medical treatment with methotrexate, then suction curettage 
under ultrasound guidance, or hysteroscopic resection can suffice. All patients 
with extra-tubal pregnancy should be well counseled about the associated com-
plications, fertility preserving intervention, and need for prolong monitoring 
especially those that choose medical therapy.
Keywords: cervical, ovarian, abdominal, cesarean section scar, interstitial, 
pregnancy, medical, surgical, treatment
1. Introduction
Ectopic pregnancy is defined as the implantation of a fertilized ovum outside 
the normal endometrial lining of the uterine cavity, and it accounts for 1–2% of 
all pregnancies [1, 2]. The true incidence of ectopic pregnancy is unknown but 
it accounts for 18% of women seen in the emergency room for first trimester 
vaginal bleeding, or abdominal pain, or both [3]. Moreover, ruptured ectopic 
pregnancies are responsible for 2.7% of all pregnancy-related deaths, and it is 
the leading cause of hemorrhage-related mortality [4]. About 95% of ectopic 
pregnancies occur in the oviduct or the Fallopian tube, while the remaining 
5% occur in different locations such as the cervix, ovary, abdominal cavity and 
previous uterine scar especially cesarean section scar [5]. There have also been 




2. Etiology and risk factors
The risk factors for tubal ectopic pregnancy are well known, and this include 
poorly treated pelvic inflammatory disease (PID) mostly due to chlamydia and 
gonorrhea, history of ectopic pregnancy, tubal surgeries including tubal steriliza-
tion procedure, pelvic surgery and congenital anomalies of the Mullerian duct 
such as abnormally long fallopian tubes, unicornuate or bicornuate uterus. Other 
risk factors include infertility, smoking, use of intrauterine contraceptive device 
(Levonorgestrel impregnated or Copper IUD), and utero exposure to diethylstil-
bestrol. While the causes of extra-tubal pregnancy are less defined, it is clear that 
assisted reproductive techniques have contributed significantly to the incidence of 
all ectopic pregnancies especially the extra-tubal pregnancies [6].
3. Ovarian pregnancy
Ovarian ectopic is also a rare variant of extra-tubal ectopic pregnancy. It 
accounts for about 0.5% of all ectopic pregnancies [7]. The incidence of ovarian 
ectopic pregnancy after natural conception ranges from 1 in 2000 to 1 in 60,000 
deliveries and accounts for 3% of all ectopic pregnancies among intrauterine 
devices users [7]. Most ovarian ectopic pregnancy (OEP) will rupture before the 
end of the first trimester, but few cases that progressed to term have been reported.
Risk factors for ovarian ectopic pregnancy:
1.  Embryo migration related to the presence of certain conditions that cause 
fallopian tube epithelial damage that alters tubal motility [8].
2. A hindrance in the release of the ovum from the ruptured follicle [9].
3. Inflammatory thickening of the tunica albuginea [10].
4.  IUD insertion is the most significant risk factor for primary OEP in 57–90% 
of the cases [8, 9]. This is because IUD provider protection for intrauterine 
implantation, but it does not prevent ovarian implantation [11].
Criteria for diagnosis of ovarian pregnancy as described by Spiegelberg in 1878:
1. Fallopian tube on the ipsilateral (affected) side must be intact.
2.  The gestational sac must occupy the normal anatomical position of the ovary 
in the ovarian fossa (see Figure 1) [12].
3. The gestational sac is connected to the uterus by the ovarian ligament.
4.  Ovarian tissue must be found on the wall of ectopic pregnancy on histological 
examination [13].
3.1 Treatment
The classical management of ovarian pregnancies is surgical. Early bleeding for 
small lesson has been managed by ovarian wedge section or cystectomy [14]. With 
larger lesions, ovariectomy is most often performed and this can be performed 
via laparotomy or laparoscopy which can be used to excise the gestational sac, to 
perform laser ablation or use of bipolar electrocoagulation. Methotrexate has been 
used successfully to treat unruptured ovarian ectopic [15].
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4. Abdominal pregnancy
Abdominal pregnancy is almost always due to secondary implantation, with the 
primary sites being the tube, ovary or even the uterus. The conceptus result from 
tubal abortion into the peritoneal cavity or escapes through a rent in the uterine 
scar [16]. However, there have been reports of rare pseudo-abdominal pregnancies 
where women have abdominal pregnancy after hysterectomy with intact ovaries. 
This is most likely to have occurred via a fistula in the vaginal cuff in fertile women 
following total hysterectomy or via cervical canal following supracervical hysterec-
tomy. The average incidence is above 1 in 3000 pregnancies. With the used of ART, 
the incidence is found rising [17]. Primary implantation of the fertilized ovum on 
the peritoneum is so rare that its existence is questionable.
4.1 Diagnosis
The diagnostic criteria of abdominal pregnancy as described by Studdiford in 1942:
1. Both the tubes and ovaries are normal without evidence of recent injury.
2. Absence of utero-peritoneal fistula.
3. Presence of a pregnancy related exclusively to the peritoneal surface and early 
enough to eliminate the possibility of secondary implantation following pri-
mary nidation in the tube [18].
Apart from symptoms of lower abdominal pain and amenorrhea, symptoms 
of normal uterine pregnancy are often exaggerated such as nausea, vomiting, 
constipation and increased fetal movements. The fetal parts are felt easily and 
persistent abdominal attitude and position of the fetus on repeated examination 
is quite common. While abdominal high position the fetus is commonly found 
in intraperitoneal pregnancy, though the fetus may be lying low in intraliga-
mentary pregnancy. The cervix is not typically soft and is usually displaced 
Figure 1. 
Ovarian ectopic pregnancy. Transvaginal ultrasound showing a gestational sac located within the ovarian 
stroma (white arrow) [12].
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depending upon the position of the sac. Investigations done in case of suspected 
abdominal ectopic pregnancy include abdominopelvic ultrasound which shows 
absence of uterine wall around the fetus with close approximation to maternal 
abdominal wall and visualization of the uterus separately. Magnetic resonance 
imaging (MRI) can confirm the diagnosis and may be very accurate. Computed 
Tomography (CT) is diagnostic and superior to MRI [19]. CT has the risk of radia-
tion. Lateral X-ray on standing position shows superimposition of fetal shadow 
with the maternal spine shadow.
4.2 Treatment
Once the diagnosis is made the opinion is almost crystallized in favor of urgent 
laparotomy irrespective of period of gestation. The risks of continuation of 
pregnancy are; catastrophic hemorrhage, fetal death, increased fetal malforma-
tion and increased neonatal loss [20]. Thus, continuation of pregnancy for few 
weeks hoping the baby to become mature enough to survive can only be justified 
in exceptional circumstances such as a case where the pregnancy continued up 
to 30 weeks and eventually resulted in a live born baby [21]. The patient and her 
relatives should be informed about the eventuality. During the period, the patient 
should be in the hospital. The ideal surgery is to remove the entire sac, fetus, the 
placenta and the membranes. This may be achieved if the placenta is attached to a 
removable organ like uterus or broad ligament. However, if the placenta is attached 
to vital organs, it is better to take the fetus and leave behind the placenta and the 
sac after tying and cutting the umbilical cord close to the placental attachment. In 
such a situation, placental activity is to be monitored by quantitative serum βHCG 
level and ultrasound. Complete resorption of the placenta occurs through aseptic 
autolysis. Complications include secondary hemorrhage, intestinal obstruction and 
infection.
5. Other types of non-tubal pregnancy
The most notable of other extra-tubal ectopic pregnancy are cervical pregnancy, 
cesarean section scar pregnancy (CSP), interstitial pregnancy and also a recently 
reported case of intrahepatic pregnancy.
6. Cervical pregnancy
Cervical ectopic pregnancies (CEP) probably the rarest of all ectopic pregnan-
cies and it occurs in about 1:16,000 pregnancies, with implantation occurring in 
the cervical canal at or below the internal cervical os (see Figures 2 and 3) [7, 12, 
22–24]. The etiology and risk factors for cervical ectopic pregnancy are similar to 
those enumerated above, but previous overzealous uterine curettage with associ-
ated Asherman syndrome and in-vitro fertilization are probably the most impor-
tant risk factors. Previous cesarean section has also been implicated as a possible 
risk factor.
The condition is commonly confused with cervical abortion. In cervical preg-
nancy, the bleeding is painless and the uterine body lies above the distended cervix. 
Intractable bleeding following evacuation or expulsion of the products brings about 
suspicion. The morbidity and mortality are high because of profuse hemorrhage 
due to paucity of smooth muscles in the cervix, hence unable to contract to stop this 
bleeding.
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6.1 Diagnosis
Many criteria have been proposed for the diagnosis of ectopic pregnancy which 
include mostly the anatomical and histological criteria described by Rubin in 1911 
but later modified in 1983, the more practical criteria by Paalman and McElin and 
finally, the sonographic criteria by Raskin et al.
The (Rubin, 1983) anatomical and histological criteria for cervical pregnancy 
include
Figure 2. 
Early cervical ectopic pregnancy with embryonic pole. Transvaginal ultrasound shows: (1) an empty and 
normal uterine cavity and (2) a cervical ectopic pregnancy with gestational sac and an embryonic pole 
(arrows) [23].
Figure 3. 
Cervical ectopic pregnancy with no definite gestational sac. Transvaginal ultrasound showing an organized 
area with no definite gestational sac located within the posterior cervical stroma (white arrow) [24].
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1. Cervical gland must be opposite the placental attachment.
2. The placenta attachment to the cervix must be situated below the entrance of 
the uterine vessels or below the peritoneal reflections of the anterior or poste-
rior surface of the uterus.
3. The fetal elements must be absent from the corpus uteri.
Rubin criteria require a hysterectomy specimen to satisfy these criteria.
Clinical diagnostic criteria as described by Paalman and McElin (1959)
1. Uterine bleeding without cramping pain following a period of amenorrhea.
2. Soft, enlarged cervix equal or larger than the fundus, (the “hourglass” appear-
ance of uterus).
3. Products of conception entirely confined within and firmly attached endocervix.
4. A closed/snug internal cervical os.
5. A partially opened external os.




3. Diffused intrauterine echoes.
4. Absence of intrauterine pregnancy.
5. Empty uterus or absence of gestational sac or embryo.
6. The entire product of conception (placenta and chorionic villi) must be located 
below the internal os and the cervical canal must be dilated and barrel shaped.
Jurkovic (1996) criteria were introduced to distinguish primary cervical ectopic 
pregnancy from an aborting intra-uterine pregnancy:
1. The “sliding sign” seen on transvaginal examination must be absent.
2. The demonstration of peri-trophoblastic blood flow to the fetus by color Dop-
pler flow must be present.
7. Cesarean scar ectopic pregnancy
Cesarean scar pregnancy (CSP) accounts for 0.04–0.05 of all pregnancies [1]. 
The prenatal diagnosis of CSP is by the presence of gestational sac at the site of the 
previous uterine incision and the presence of an empty uterine cavity and cervix, as 
well as thin myometrium adjacent to the bladder (see Figure 4) [25, 26]. Cesarean 
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scar pregnancy can be classified based on the degree of invasion of amniotic sac into 
the myometrium, gestational age at diagnosis, presence of positive fetal heart beats 
and myometrial thickness of the lower uterine segment. The management of these 
rarer forms of ectopic pregnancy is just evolving.
Diagnostic criteria of cesarean scar ectopic pregnancy:
1. Empty uterus with clearly visualized endometrium.
2. Empty cervical canal.
3. Gestational sac within the anterior portion of the lower uterine segment at the 
presumed site of the cesarean scar.
4. Thinned or absent myometrium below the gestational sac and bladder (< 5 mm 
in two-thirds of cases) [27].
8. Cornual pregnancy
One of the most intriguing of ectopic pregnancies is the cornual or interstitial 
pregnancy, though not strictly extra-tubal pregnancy. It is neither located in the 
normal endometrial cavity nor in the normal fallopian tubes, but in the proximal 
portion of the tube and within the musculature of the uterus. The discussion on 
extra-tubal pregnancy cannot be complete without pointing out the implications 
of late diagnosis or misdiagnosis of cornual pregnancy; a potentially dangerous 
ectopic pregnancy. Often times, it can be mistaking for an intrauterine pregnancy 
thereby continuing till late first trimester, about 10–12 weeks of gestation. When it 
ruptures, it can result in rapid catastrophic hemorrhage because of the involvement 
of the well-vascularized muscular myometrium, and can cause significant maternal 
morbidity or mortality.
Diagnostic criteria of cornual ectopic pregnancy, 1992 [28]:
1. An empty uterine cavity.
Figure 4. 
Cesarean section scar ectopic pregnancy. Transvaginal ultrasound with 2-D and power Doppler showing: (1) normal 
uterine cavity and endometrium, (2) gestational sac in the cesarean section scar anteriorly, and (3) the vasculature 
around the gestational sac (white arrows) [25]. (A) shows cesarean ectopic pregnancy on a gray-scale ultrasound, 
and (B) shows the same pregnancy on color Doppler showing ring of fire of vessels around the gestational sac.
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2. A chorionic sac found separated (> 1 cm) from the lateral edge of the 
uterine cavity.
3. A thin (< 5 mm) myometrial layer surrounding the chorionic sac.
9. Diagnosis of non-tubal ectopic pregnancies
9.1 Pregnancy of unknown location (PUL)
Usually, the absence of intrauterine pregnancy, adnexal mass or abnormally 
rising serum beta hCG without evidence of intrauterine gestation are not always a 
confirmation of ectopic pregnancy. In the absence of any ultrasound evidence of 
visible pregnancy, the terminology of pregnancy of unknown location (PUL) is use. 
The prevalence of PUL is between 8 and 31% and it can be influenced by the quality 
of ultrasonography in the given unit, and the experience of the ultrasonographer [29, 
30]. Even when PUL is being suspected, there is usually no place for diagnostic suction 
and curettage to determine the location of the pregnancy because this will disrupt 
a potential intrauterine pregnancy. Sometimes, some cases of PUL may evolve into 
ectopic pregnancy; tubal or non-tubal that may cause life threatening complications.
9.2 Ectopic pregnancies
Transvaginal ultrasound (TVUS) is the first line tool and the gold standard 
diagnostic apparatus of ectopic pregnancy. Ectopic pregnancy is usually diagnosed 
on TVUS as the presence of a mass with hyperechoic ring around the gestational sac 
(“bagel sign”) or a gestational sac with a fetal pole with or without cardiac activity. 
The sensitivity and specificity of TVUS in detecting ectopic pregnancy are 90.9 and 
99.9%, respectively, with positive and negative predict values of 93.5 and 99.8%, 
respectively. Another ultrasound feature of ectopic pregnancy is the trilaminar 
pattern of endometrial thickness with sensitivity of 38% and specificity of 94% for 
detecting ectopic pregnancy [31]. Magnetic resonance imaging is useful as a trou-
bleshooting tool when ultrasound is equivocal or inconclusive before intervention 
or therapy [27]. Sagittal, coronal, and transverse sections of T1- and T2-weighted 
magnetic resonance imaging sequences can be used to show the gestational sac 
embedded in the anterior lower uterine segment, better evaluate pelvic anatomy, 
improve intra-operative orientation, and assess the possibility of myometrial inva-
sion and bladder involvement [27, 32, 33]. Magnetic resonance imaging can also be 
used to measure the volume of the lesion so as to help assess whether methotrexate 
will be indicated and to predicts its success as medical intervention [27].
10. Management of non-tubal pregnancy
The management of extra-tubal ectopic pregnancy depends on the location, size 
of the gestational sac, presence of fetal heart beats and symptoms at presentation. 
The definitive management of extra-tubal ectopic pregnancy involves surgical 
extermination of the gestational sac via laparotomy, laparoscopy, hysteroscopy 
or suctional curettage under ultrasound guidance. Another advantage of surgical 
extermination is that there is confirmation of ectopic pregnancy by histological 
evidence of the presence of villi within the stroma of the affected structure.
Preservative procedures such as placement of cerclage; a pulse-string suture 
or cervical plugging have been proposed as adjunct treatment for cervical ectopic 
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pregnancy. Methotrexates therapy either systemic and /or local injections directly 
into the gestational sac or intracardiac potassium chloride injection have also been 
used especially when there is associated embryonic cardiac activity. Uterine artery 
embolization with Gelfoam has also been used successfully to control hemor-
rhage. However, hysterectomy is often required to control intractable bleeding. 
Occasionally, there may be no need for intervention due to declining serum beta 
hCG levels in asymptomatic patients; however, these patients are usually closely 
monitored to ensure spontaneous resolution of the pregnancy.
11. Medical management
11.1 Methotrexate
Methotrexate is a chemotherapeutic anti-metabolite that affects rapidly divid-
ing cells, and it is use in the treatment of cancers and connective tissues disorders 
such as rheumatoid arthritis. The use of Methotrexate in the medical manage-
ment of ectopic pregnancy has to be thoroughly given serious consideration to 
avoid inadvertent administration in patient with intrauterine pregnancy. Hence, 
careful selection of appropriate candidate for Methotrexate treatment to improve 
success rate is advised. In most instances, Methotrexate should only be given to 
patients with confirmed or presumed ectopic pregnancy who are hemodynami-
cally stable with an unruptured gestational sac. The success rate is also depen-
dent on the level of serum beta hCG because single-dose systemic Methotrexate 
had approximately 90% success rate if the initial serum hCG level is less than 
5000 mIU/ml [34].
The indications and contraindications of Methotrexate should be reviewed 
before every use. For some extra-tubal pregnancies like CSP and cervical pregnan-
cies, use of Methotrexate may be considered as the first and only option before 
surgical intervention to minimize catastrophic hemorrhage. The higher the level of 
serum beta hCG, the more likely the failure rate of using methotrexate in medical 
management of all ectopic pregnancies. In view of this, some experts have recom-
mended use of two-dose or multiple-dose regimens for such patients if they are 
not surgical candidates and medical management is warranted. Lipscomb et al. 
demonstrated that a high serum hCG level is the most important factor associated 
with failure of treatment with single-dose MTX protocol among women with tubal 
ectopic pregnancy [35].
Contraindications to methotrexate therapy [36, 37].
Absolute contraindications
1. Pregnancy of unknown location of only one evaluation.
2. Peptic ulcer disease.
3. Intrauterine pregnancy.
4. Sensitivity to methotrexate.
5. Breastfeeding.




8. Active pulmonary disease.
9. Unwilling or unable to return for follow up visits.
Relative contraindications
1. Gestational sac >3.5 cm.
2. Embryonic cardiac motion.
3. Hepatic, renal, or hematologic dysfunction.
4. Serum beta hCG > 5000 mIU/ml.
11.2 Pre-treatment evaluation
Blood type, serum hCG (to be used as “Day 1” level).
Safety labs: full blood counts, complete metabolic panel consisting of AST/ALT, 
BUN/Cr, also to be repeated prior to additional MTX dosing.
11.3 Systemic methotrexate treatment protocol
Systemic methotrexate is usually given as a single-dose or two-dose or fixed 
multi-dose regimens. The single-dose regimen of 50 mg of methotrexate per body 
surface area (BSA, m2) is usually given only on the first day, then followed by serial 
monitoring of serum hCG on days 4 and 7. There is the possibility of repeating 
the same dose on days 7 and 11 if there is less than 15% drop in the levels of hCG 
between days 4 and 7 or between days 7 and 11. The two-dose regimen also uses 
50 mg of methotrexate per BSA (m2) and it is predetermined to be given on days 1 
and 4, then followed by serial serum hCG levels on days 4 and 7 or 11. There is also 
a possibility of repeating the same dose on days 7 and 11 if the drop in serum hCG 
levels between days 4 and 7 or days 7 and 11 are less than 15% respectively [36, 37].
The fixed multi-dose regimen uses 1 mg of methotrexate per kilogram body weight 
for a total of four doses given on alternate days; on the first, third, fifth, and seventh 
days while Folinic acid rescue is given on the second, fourth, sixth, and eighth days. This 
regimen requires serial serum hCG monitoring on the days of methotrexate injections 
until there is more than 15% drop from the previous level. Thereafter, continue weekly 
to every 4 weeks monitoring until the serum hCG levels is less than 5 mIU/ml [36, 37].
Methotrexate can also be injected locally into the gestational sac or in the fetal 
intracardiac space to enhance resolution of the pregnancy. This is usually done 
under ultrasound guidance and it is given in combination with systemic injection in 
various dosing regimens. Timor-Tritsch et al. suggested using a fixed dose of 75 mg 
of methotrexate; 25 mg intracardiac injection, 25 mg inside the gestational sac while 
the remaining 25 mg is given intramuscularly (Table 1).
11.4 Adjuvant medical treatments and other interventions
Give anti-D immunoglobulin injection if patient is rhesus negative.
Advise patient to discontinue folic acid supplementation during MTX treatment.
Avoid pelvic exams and sexual intercourse during treatment period.
Caution patients: to reduce gastrointestinal side-effects, avoid alcohol and non-
steroidal anti- inflammatory drugs (NSAIDs).
Avoid prolonged exposure to sun due to sun hypersensitivity while on MTX.
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Avoid new conception until serum hCG is undetectable.
Combination of systemic and local injection of methotrexate.
Timor-Tritsch recommendation of combined local and systemic injection:
A. 25 mg intragestational sac.
B. 25 mg into the placental site as the needle is being withdrawn.
C. 25 mg intramuscular prior to patient discharge from the hospital.
University of Illinois at Chicago protocol (unpublished):
A. Half dose of 50 mg/m2 BSA injected into the intragestational sac.
B. The remaining half dose of MTX is injected intramuscularly.
11.5 Potassium chloride
In the presence of cardiac activity, intracardiac injection of potassium chloride 
with 2 mEq/L under ultrasound guidance, and repeat until there is no longer 
Single-dose regimen
Days Activities performed
1 MTX 50 mg/m2 IM injection.
4 and 7 Measure hCG levels, a rise may be seen on 
Day 4 compared to baseline Day 1.
If ≥15% drop from Days 4 to 7, continue to follow weekly until hCG < 5 mIU/ml.
If <15% drop from Days 4 to 7, repeat MTX 50 mg/m2, repeat serum hCG on Day 11.
Two-dose regimen
Days Activities performed
1 MTX 50 mg/m2 IM injection.
4 MTX 50 mg/m2 IM injection and serum 
hCG level.
7 Serum hCG level, if ≥15% from Days 4 to 
7, continue weekly until hCG < mIU/ml.
If <15% drop from Days 4 to 7, repeat MTX 50 mg/m2 and check hCG on Day 11; if ≥15% drop from Days 7 to 
11, continue to follow up weekly until hCG < 5 mIU/ml.
If <15% drop from Days 7 to 11, repeat MTX 50 mg/m2 and check hCG on Day 14; if ≥15% drop from Days 11 
to 14, continue to follow weekly until hCG < 5 mIU/ml.
Fixed multi-dose regimen
Days Activities performed
1, 3, 5, 7 MTX 1 mg/kg body weight.
2, 4, 6, 8 Folinic acid 0.1 mg/kg body weight.
Measure serum levels of hCG on MTX dose days; continue dosing until hCG decreases ≥15% from previous 
measurement.
Follow hCG until <5 mIU/ml.
MTX, methotrexate; hCG, human chorionic gonadotropin; IM, intramuscular.
Table 1. 
Different regimens of systemic methotrexate.
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cardiac activity. It usually requires 2–3 ml injections for the procedure. Potassium 
chloride can be used as a stand-alone treatment intervention in ectopic pregnancy 
or in combination with any of the methotrexate injection regimens. In a study of 
18 ectopic pregnancies with active embryonic cardiac activity, mean serum beta 
hCG levels of 33,412 IU/L and mean gestational age of 6 weeks and 6 days, 10 were 
assigned to KCL injection in the gestational sac while 8 were in the methotrexate 
group. There was no difference in time to resolution of ectopic pregnancies between 
those injected with KCL and those with methotrexate [38]. Verma et al. in a three-
case series of women with concurrent injection of local KCL and systemic injection 
of methotrexate, they demonstrated that complete resolution of ectopic pregnancy 
was achieved and surgery avoided in all 3 cases [39].
11.6 Newer treatment combinations
The use of selective progesterone reception modulator (Mifepristone) as an 
adjuvant for medical therapy has been tried. In a randomized trial by Rozenberg 
et al., there was no benefit from the systematic addition of mifepristone except 
in women with progesterone level of 10 ng/L or more [40]. However, in a larger 
study involving 72 patients; 30 with combined methotrexate-mifepristone and 42 
with methotrexate alone by Perdu et al., the failure rate was lower in the combined 
group, 1/30 (33.3%) compared to 11/42 (26.2%) in the methotrexate alone group 
[41]. Use of epidermal growth factor receptor inhibition in combination with 
methotrexate has been tried in an in vitro experiment and it showed inhibition of 
growth of placental cells. These results were confirmed in vivo in mouse models, 
and it revealed faster rate of fetal resorption when the two drugs were combined 
[42]. In a phase 1 nonrandomized open label study involving 12 women with 
ectopic pregnancy and 71 controls, the median level of serum beta hCG by day 7 
and the time of pregnancy resolution were significantly lower in the combined 
methotrexate and epidermal growth factor receptor blocker (gefitinib) compared 
with methotrexate alone group [43]. Hence, the future goal of medical management 
of extra-tubal ectopic pregnancies should be combination therapy ab initio with 
various methotrexate regimen.
12. Surgical management of non-tubal pregnancy
To ensure complete removal of a tubal ectopic pregnancy, a British surgeon, 
Robert Lawson Tait performed a laparotomy with ligation of ruptured tube and 
board ligament in April 1883. By the 1920s, laparotomy and ligation of the bleeding 
vessels with removal of the affected tube had become the standard of care, and it 
remained so until the late 1970s, when operative laparoscopy and salpingectomy 
replaced laparotomy and salpingectomy. For CSPs, nearly 50% of clinically diag-
nosed cases miscarriage during the first trimester but most of them will require 
additional surgical intervention to stop bleeding [44]. Surgical management of 
any ectopic pregnancy is associated with a high success rate; low complication rate 
and short post-treatment follow up [19]. In a national cohort study in the UK by 
Hart et al. of 102 cases of CSP, the success rates of expectant, medical and surgical 
management were 43% (9/21), 46% (7/15) and 96% (54/56), respectively. The 
complication rates were 15/21 (71%) with expectant, 9/15 (60%) with medical and 
20/56 (36%) with surgical management. Discharge from care (median number of 
days) was 82 (range 37–174) with expectant, 21 (range 10–31) with medical and 11 
(range 4–49) with surgical management [45].
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12.1 Suction curettage
This surgical intervention has been used to treat appropriately selected suitable 
patients with cervical ectopic or cesarean scar ectopic pregnancies. It is usually done 
under transabdominal or transrectal ultrasound guidance to ensure direct visualiza-
tion of the pregnancy sac during the procedure. This procedure has been used for 
cervical ectopic pregnancy (CEP) and CSP despite the fear of potential catastrophic 
hemorrhage that may warrant emergency hysterectomy or may result in significant 
maternal morbidity and mortality. When suction curettage is being considered as 
a treatment option, you also need to plan for possible use of adjuvant interventions 
to reduce excessive blood loss. Adjuvant methods that have used so far include but 
not limited to intracervical balloon tamponade, angiographic embolization, cervical 
cerclage, ligation of uterine arteries or local hysteroscopic endocervical resection 
of the gestational sac with local use of different substances. Among these, arterial 
embolization has gained more recognition than any other interventions to decrease 
potentially dangerous massive hemorrhage thought to be associated with suction 
curettage of CSP or cervical ectopic pregnancy. However, there have been reports of 
suction curettage used successfully to evacuate CEP or CSP with minimal complica-
tions. In a study by Jurkovic et al. of 232 women with CSP, suction curettage was 
an effective method for the treatment of 191 pregnancies implanted into the lower 
uterine segment cesarean section scar because of the 116 women who had a follow 
up visit, only 7 (6.0%), 95% CI 1.7–10.3% required a repeat surgical procedure for 
retained products of conception. It was associated with a low risk of blood transfu-
sion and hysterectomy. Of the 191 women, 9 (4.7%) required blood transfusion, 
95% CI 1.7–7.7, and 1 (0.5%) women had life-saving hysterectomy due to uncontrol-
lable intraoperative hemorrhage [46].
12.2 Wedge resection
Wedge resection of gestational sac can be used for many extra-tubal pregnan-
cies such as CSP, ovarian or cornual pregnancies. There have been multiple case 
reports on the safety and effectiveness of wedge resection of CSP via laparotomy. 
Wedge resection should be considered when the diagnosis is made early, there is no 
involvement of vital contiguous structures and need for preservation of fertility. 
In a case report by Vial et al. of 28 years old G3P2002 at 6 weeks gestation, wedge 
resection of the gestational mass via a Pfannenstiel incision resulted in complete 
resolution of the pregnancy and subsequent full-term pregnancy delivered by 
cesarean section [47]. Traditionally, wedge resections of the gestational sac or 
hysterectomy via laparotomy is the treatment of choice of interstitial or cornual or 
angular pregnancy. However, laparoscopic cornuotomy is the removal of ectopic 
pregnancy tissue with preservation of uterine architecture. This increases incidence 
of persistent and recurrent interstitial pregnancy, but can potentially maintain 
patient fertility and decrease risk of future uterine rupture. Patients with cornual 
resection are often delivered at 36–37 weeks of gestation via cesarean section in 
subsequent pregnancies because of their increased risk of uterine scar rupture. In 
a study of 29 patients by Liao et al., the incidence of subsequent uterine rupture 
and dehiscence was 30% [48]. However, there is still controversy in regards to the 
recommended surgical technique to treat interstitial pregnancies; cornual resection 
and cornuectomy are both important considerations.
A small ovarian ectopic pregnancy (OEP) or early bleeding can be treated 
with wedge resection or cystectomy with the intention to preserve some of 
the affected ovarian tissues. There have been anecdotal case reports of the 
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effectiveness of wedge resection in the treatment of OEP. A case report by 
Kraemer et al. showed a 29-year-old G1P0 at 8 weeks gestation with confirmed 
ovarian pregnancy and she was managed by laparoscopic wedge resection of 
the OEP. She subsequent was pregnant with a normal intrauterine pregnancy 
6 months after her surgery [49].
12.3 Laparotomy/laparoscopy in extra-tubal pregnancy
Directly visualization of the pregnancy via laparotomy or laparoscopy may 
be helpful in the definitive diagnosis of OEP and abdominal pregnancy. Surgical 
management of either of the two pregnancies is influenced by the size of the 
lesion, the proximity or attachment to vital organs, associated symptoms and the 
patient’s desire for future fertility [46]. Small OEP are usually treated conserva-
tively with wedge resection, enucleation, cystectomy, or trophoblast curettage 
with electrocoagulation or hemostatic suture to preserve fertility. However, large 
OEP may require oophorectomy when there are no apparent normal ovarian 
tissues left [47].
12.4 Adjuvant surgical interventions
The use of adjuvant interventions is to accelerate the efficacy of primary 
treatment or to minimize potential life-threatening complications. Intracervical 
balloon tamponade or cervical cerclage have been used during cervical curettage 
for cervical ectopic pregnancy to decrease bleeding. Direct ultrasound-guidance 
is helpful for all extra-tubal pregnancy to enable injection of methotrexate or KCL 
or hyperosmolar glucose into the gestational sac. Misoprostol and Methergine 
are uterotonic agents that cause vasoconstriction, thereby reducing the amount 
of blood loss during surgical intervention. Careful and appropriate use of these 
adjuvant treatments can improve successful outcome of primary treatment of 
extra-tubal pregnancy.
13. Conclusion
Ectopic pregnancy is the leading cause of first trimester maternal mortality, 
and it is mostly located in the fallopian tubes. When it is located outside the 
tubes, the need for high index of suspicious and prompt intervention is advised 
because the more advanced extra-tubal pregnancies can result in catastrophic 
hemorrhage or maternal death. Different surgical techniques that are unique to 
individual type of ectopic pregnancy, the use of methotrexate and combination 
therapy have all demonstrated proven benefits for the treatment of extra-tubal 
pregnancy.
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Cervical Pregnancy Diagnosis and 
Management
Rubens Bermudes Musiello, Jair Luiz Fava, Luiz Camano  
and Eduardo de Souza
Abstract
Cervical ectopic pregnancy is rare. Cervical implantation is a serious obstetric 
condition that can lead to mutilation if not promptly diagnosed and treated. The 
clinical diagnosis consists in physical examination, ballooned cervical canal, 
dilated cervix, and hourglass-shaped uterus detected by internal examination. 
Ultrasonography confirms the diagnosis by visually detecting cervical implanta-
tion below the internal orifice. Magnetic resonance imaging and three-dimensional 
ultrasonography validates the diagnosis. Conservative treatment proposed: cerclage, 
vasopressin, Foley catheter with hemostatic cervical ligation, cervical canal balloon, 
embolization of uterine artery, hysteroscopy, laparoscopic ligation of the uterine 
artery, and curettage by suction catheter. Shortcomings of conservative management 
are high, and a number of cases result in hysterectomy. Drug management is a thera-
peutic option to avoid mutilating surgery, and the most commonly used is systemic 
methotrexate (MTX). Local treatment with MTX and potassium chloride injection 
guided by transvaginal ultrasound is used when the embryo is alive.
Keywords: pregnancy, ectopic, cervical, methotrexate
1. Introduction
Ectopic pregnancy (EP) is a pregnancy in which the fertilized egg attaches itself 
and develops outside the uterus.
Cervical ectopic pregnancy (CEP) is considered to be exceptionally rare, and 
it accounts for less than 1% of ectopic pregnancies (EP) [1, 2]. Its exact incidence 
is not yet known; some authors report from 1:978 to 1:50,000 [1, 3–8], and other 
authors report 0.1% of all EP, estimating their incidence between 1:2500 and 
1:98,000 pregnancies [9].
The first description of cervical pregnancy dates back to 1817 in England by 
Sir Everard Home [10], though the term was first used by Rokitansky in 1860 [11] 
(Figure 1).
The implantation represents a serious obstetric event [12, 13], to an extent that 
in 1953, Baptiste reflected: “Most great obstetricians have never seen a case of CEP; 
however, a minority who had this opportunity wish they had never seen it.”
Some risk factors have been considered for cervical nidation of the egg: anatomi-
cal abnormalities, uterine leiomyomas, synechia, previous cervical interventions 
leading to cervical mucosal changes, cervical stenosis, in vitro fertilization with 




Clinical diagnosis: Physical examination—Arrow at the bottom shows external orifice of the cervix, and the 
arrow at the top shows development of cervical pregnancy in the anterior lip of the cervix.
When the zygote attaches itself in the cervical canal, it is rapidly invaded by 
the trophoblast, reaching the conjunctival portion of the cervix, once there is no 
adequate decidualization. As the pregnancy develops in the cervix, bleeding could 
occur, initially in small amounts and later in greater volume when it reaches larger 
vessels. These pregnancies last, in average, 7–10 weeks [14].
2. Clinical diagnosis
The clinical diagnosis consists in the physical examination where a ballooned 
cervical canal and a dilated cervix can be detected [15] and hourglass-shaped uterus 
can be observed by internal examination [8] (Figure 2).
The differential clinical diagnosis between CEP and the ongoing miscarriage 
is that in the former, the body of the uterus tends to be larger, with dilation of the 
Figure 1. 
A case where hysterectomy was inevitable due to the hemorrhagic condition—The trophoblastic invasion in the 
endocervix can be seen (own source).
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external and internal orifice of the cervix, and it is possible to detect placental tissue 
above the internal orifice; in the latter, the internal orifice is virtually closed [16].
3. Imaging
More recently, ultrasonography has been confirming the diagnosis by visu-
ally detecting cervical implantation below the internal orifice (IO) [17, 18]. 
Transvaginal ultrasonography is the gold standard preliminary method for accurate 
diagnosis [19].
The ultrasound findings for the diagnosis of cervical pregnancy are empty 
uterine cavity, endometrial thickness due to decidual reaction, hourglass shape of 
the uterus, enlargement of cervical canal, gestational sac located in the cervix with 
or without embryo, placental tissue surrounding the gestational sac, and closed 
internal orifice of the cervix (Figure 3).
Three-dimensional ultrasonography is also useful in the diagnosis of GC [20, 21].
Magnetic resonance imaging validates the diagnosis [22, 23] (Figure 4).
4. Management
The classical treatment used to be total hysterectomy due to profuse bleeding. 
However, some authors, eager to keep their nulliparous patients’ fertility, tried the 
conservative treatment of uterine curettage or local suture [15, 16, 24].
Figure 3. 
Diagnosis by imaging—Ultrasonography showing ovular implantation below internal orifice of the cervix.
Figure 4. 




Reviewing the literature CEP was only cited only in the ninth edition of Williams 
Obstetrics in 1945. The treatment proposed at that time was [25] blood transfusion, 
vaginal tamponade and hysterectomy [26].
5. Conservative surgical treatment
The conservative surgical treatment proposed in the literature are:
1. Cerclage [27]
2. Foley catheter with hemostatic cervical ligation [28, 29]
3. Uterine curettage by suction catheter [30–33]
4. Hysteroscopy [19, 34]
5. Laparoscopic ligation of the uterine artery [35]
However, the majority of the conservative surgical treatments fail and result in 
hysterectomy.
6. Medical treatment
The following drugs are used in the medical treatment:
1. Vasopressin [36]
2. Actinomycin D and cyclophosphamide [37]
3. etoposide [38]
4. Intra-amniotic and systemic methotrexate (MTX) and potassium chloride 
with live embryo [39, 40]
5. Intramuscular methotrexate with dead embryo [41]
Among the drugs mentioned above, methotrexate (MTX) is the most used in the 
current literature for the treatment of EP. It is an antimetabolic chemotherapeutic 
and folic-acid antagonist which operates through the competitive inhibition of the 
dihydrofolate reductase enzyme, which in turn reduces the dihydrofolic acid into 
folinic acid [42], interfering the DNA synthesis and, consequently, the cell division.
Our experience advocates the therapy using a single dose of MTX as first-line 
treatment for CEP if the embryo does not show cardiac activity.
In cases of embryos without heart beating with high β-hcg titers greater than 
5000 mui/ml and often greater than 10,000 mui/ml, a systemic treatment with 
multiple doses of MTX is the preferred therapeutic.
When the embryo has cardiac activity, local treatment with MTX and potassium 
chloride is recommended [40]. Elito et al. published a series of eight cases of CEP 
where embryos are presenting cardiac activity treated with puncture of gestational 
sac guided by vaginal ultrasonography with MTX injection (1 mg/kg) and KCl 
injection [42].
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7. Expectant management
We can rarely adopt the expectant management, monitoring throughout the 
development of the cervical pregnancy, as some cases can spontaneously solve 
itself. Patients with small-volume CEP and low and declining serum beta-hCG 
concentrations are candidates for this type of management. Titers of beta-hCG 
lower than 1500 mIU/ml and declining indicate a high possibility of spontaneous 
involution.
8. Conclusion
According to the historical evolution of CEP, the treatment was carried out with 
total abdominal hysterectomy in a heroic attempt to solve the hemorrhage after 
the rupture of the cervix. When the authors began to try a traditional treatment, it 
was usually a surgery. Early diagnosis of CEP is extremely important for choosing 
the appropriate treatment. Several treatment options can be used, such as surgical 
interventions, medical treatment, and expectant management. The treatment with 
MTX has a high rate of success, and it is the first choice. CEP with cardiac activity is 
treated with intra-aminiotic MTX and potassium chloride injection. In cases of CEP 
without heart beating, systemic treatment with MTX should be used in a single- or 
multiple-dose regimen depending on the levels of beta-hCG. When the levels of 
beta-hCG are low and declining, the expectant management may be chosen. The 
clinical treatment of CEP prevents mutilating surgeries, and the patient can pre-
serve their original condition for an obstetric future.
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Caesarean Scar Ectopic Pregnancy
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Abstract
Caesarean scar ectopic pregnancy (CSEP) is one of the rarest forms of ectopic 
pregnancy. It is characterised by a gestation implanted in a caesarean section scar 
and surrounded by the myometrium and the fibrous tissue of the scar. With ris-
ing caesarean delivery rates and widespread use of ultrasound in early pregnancy, 
there is a parallel upward trend in the incidence of CSEP. The most significant risk 
associated with a CSEP is an early uterine rupture with life-threatening maternal 
haemorrhage leading to hysterectomy and loss of reproductive potential. An early 
diagnosis can offer conservative treatment options capable of preserving the uterus. 
This chapter discusses the clinical presentation, diagnosis and evidence-based 
treatment options of CSEP.
Keywords: scar ectopic pregnancy, caesarean section, complications of early 
pregnancy, uterine rupture
1. Introduction
CSEP is one of the rarest forms of ectopic pregnancies [1–5]. However, in the 
last two to three decades, an increasing number of case reports and case series have 
been published [4]. CSEP results from the implantation of the embryo in a previous 
caesarean scar (CS) instead of the endometrial cavity [6]. The pregnancy is sur-
rounded by the myometrium and the fibrous tissue of the scar. It usually manifests 
with painless vaginal bleeding and often misdiagnosed as spontaneous miscarriage 
or cervical ectopic pregnancy [1, 4]. A misdiagnosis or a late diagnosis of CSEP can 
result in early uterine rupture with life-threatening maternal haemorrhage leading 
to hysterectomy and loss of reproductive potential [6]. Ultrasonography with colour 
flow Doppler is the primary diagnostic tool in the workup of CSEP [4]. An early 
diagnosis can offer conservative treatment options that enable the preservation of 
the uterus [2, 5, 6].
2. Epidemiology
The exact incidence of CSEP is unknown. It is estimated to occur in 0.05–0.4% 
(1 in 1800 to 1 in 2500) of all pregnancies [1]. A recent publication from the UK’s 
Early Pregnancy Surveillance Service (UKEPSS) reported an estimated incidence of 
1.5 per 10,000 maternities [7]. The incidence of CSEP is rising, which is believed to 
be due to the increasing caesarean delivery rate itself and improved detection rate as 
a result of widespread use of ultrasonography during early pregnancy [8].
CSEP has been reported in women with only one previous caesarean delivery 
as well as in those with multiple caesarean deliveries. It is not clear whether the 
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number of previous caesarean delivery (CD) or the time interval between the 
CD and subsequent pregnancy affect the incidence of CSEP. Similar to other 
types of ectopic pregnancies, CSEP has been reported in both spontaneously 
conceived pregnancy as well as after in vitro fertilisation (IVF) and embryo 
transfer [9, 10].
3. Pathophysiology
The exact cause and mechanism are not well understood. The most plausible 
mechanism is that the blastocyst implants into microtubular tracts, which persisted 
at the site of the caesarean scar as a result of incomplete healing [1]. However, it 
is not clear if an increase in the number of previous caesarean deliveries or short 
interval between caesarean delivery and subsequent pregnancy increase the risk of 
CSEP by way of affecting the healing process at the caesarean scar. Additionally, 
there is no evidence if uterine closure technique (e.g. single vs. double layer closure) 
has any effect on the risk of CSEP.
Two types of CSEP have been described [8]. Type I (endogenic type) is char-
acterised by implantation on the CS with progression towards the direction of the 
endometrial cavity. Type II (exogenic type) CSEP is a deep implantation in the CS 
defect growing mainly towards the abdominal cavity. Type I CSEP can potentially 
continue to develop into the endometrial cavity and may even progress to the sec-
ond and third trimesters. Type II is associated with early uterine rupture or invasion 
into the urinary bladder [8].
CSEP should be differentiated from placenta accreta or increta, where the 
pregnancy is intrauterine with an invasion of the trophoblast into the myometrium. 
In contrast, CSEP is characterised by a gestation separated from the endometrial 
cavity and surrounded by the myometrium and the fibrous tissue of the scar.
4. Clinical presentation and diagnosis
A large proportion of patients with CSEP are asymptomatic and diagnosed 
incidentally during a routine first-trimester ultrasound [1, 4]. The most frequent 
symptom of CSEP is light and painless vaginal bleeding [4, 6]. Some patients 
may have associated mild to moderate lower abdominal pain. Severe pain with or 
without haemodynamic instability, may indicate ruptured CSEP. There may be mild 
lower abdominal or uterine tenderness on palpation; however, clinical examination 
in stable women is usually unremarkable. The gestational age at diagnosis ranges 
from 5 to 16 weeks, with an average of 7.5 ± 2.5 weeks [4].
4.1 Investigations
4.1.1 Serum beta – human chorionic gonadotropin (hCG)
Quantitative serum beta-hCG measurement confirms the presence of preg-
nancy, and also provides a baseline for posttreatment follow up.
4.1.2 Ultrasound
Ultrasonography is the primary diagnostic tool [1, 4, 6]. Transvaginal 
ultrasound (TVS) has a diagnostic sensitivity of around 85% [1, 4]. There are 
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proposed ultrasound diagnostic criteria, allowing a differential diagnosis from 
cervical ectopic pregnancy and miscarriage. These include (1) Empty uterus 
with clearly visualised endometrium, (2) Empty cervical canal, (3) Gestational 
sac located within the anterior isthmic portion of the uterus at the presumed 
site of the CS, (4) Thinned (<5 mm) or absent myometrium between the 
gestational sac and bladder [5]. Additionally, Doppler colour flow may show 
distinct circular peritrophoblastic perfusion surrounding the gestational sac 
(see Figures 1 and 2).
The crossover sign (COS) is an ultrasound sign that is proposed to describe the 
relationship between the gestational sac, the caesarean scar and the anterior uterine 
wall [12]. In a sagittal view of the uterus a straight line connecting the internal os 
and the uterine fundus through the endometrium is drawn (endometrial line). The 
superior–inferior (S-I) diameter of the gestational sac, perpendicular to the endo-
metrial line, is traced (see Figure 3).
Figure 1. 
Transvaginal ultrasound, sagittal view of a gestational sac with a yolk sac within a caesarean scar [11].
Figure 2. 
Transvaginal ultrasound, sagittal view with colour Doppler demonstrating peritrophoblastic perfusion [11].
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Patients can be categorised into groups based on the relationship between the 
endometrial line and the S-I diameter of the gestational sac [12]:
1. Normal - gestational sac implanted away from the caesarean scar and close to 
the fundus.
2. COS-1 - gestational sac implanted within the caesarean scar and at least two-
third of the S-I diameter of the gestational sac is above the endometrial line.
3. COS-2+ - gestational sac implanted within the caesarean scar and less than 
two-third of the S-I diameter of the gestational sac is above the endometrial 
line.
4. COS-2− - gestational sac implanted within the caesarean scar and less than 
two-third of the S-I diameter of the gestational sac is above the endometrial 
line, but there is no intersection between the S-I diameter and the endometrial 
line (see Figure 4).
This categorisation based on the COS may help to determine the natural progres-
sion of CSEP [12].
4.1.3 Magnetic resonance imaging
Magnetic resonance imaging (MRI) is rarely required to clarify the diagnosis of 
CSEP [1]. Sagittal, coronal and transverse sections of T1- and T2- weighted MRI 
sequences can clearly show the gestational sac embedded in the anterior lower 
uterine wall [5] (Figure 5). MRI can also help in decision making and pre-operative 
planning through detailed characterisation of CSEP location, depth of myometrial 
invasion and presence of bladder involvement [1, 5] (Figure 6).
Figure 3. 
Diagrammatic representation of relationship between gestational sac, caesarean scar and anterior uterine wall, 
defined as crossover sign (COS) [12]. (a) Normal implantation, (b) COS-1, (c) COS-2+, (d) COS-2−.
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Figure 4. 
Ultrasound images of different types of crossover sign (COS): (a) COS-1, (b) COS-2+ and (c) COS-2−. 
B = bladder, C = cervix, CS = caesarean scar, EL = endometrial line, GS = gestational sac, SID = superior–
inferior diameter [12].
Figure 5. 




CSEP can be mistaken for spontaneous miscarriage in progress [11, 13] or cervi-
cal ectopic pregnancy [13]. In cervical pregnancy, unlike CSEP, there would be a 
layer of myometrium visible between the bladder and the gestational sac and bleed-
ing as the presenting symptom is much more substantial [5, 6, 11, 13]. The uterus 
Figure 7. 
Cervical ectopic pregnancy: Hourglass appearance of the uterus with gestational sac in the intracervical 
canal [14].
Figure 6. 
Surgical specimen of a total hysterectomy from a case of a 2nd trimester CSEP. Note the distended lower 
segment of the uterus with near total absence of myometrium at the previous caesarean scar.
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is empty with an endometrial stripe, the gestational sac presents predominantly 
within the cervix, giving an hour-glass shape of the uterus with a ballooned cervi-
cal canal (see Figure 7) [5, 6, 14]. In case of spontaneous miscarriage in progress, 
an avascular gestational sac is seen in the cervical canal indicating that it has been 
detached from its implantation site, in contrast to the well-perfused CSEP located 
in the anterior lower uterine wall [5, 13]. A significant fall in serum beta-hCG level 
would also be noticed in a miscarriage.
5. Treatment
Due to the rarity of CSEP, there is no consensus regarding its management. 
Treatment options discussed here are mostly based on case reports and small case 
series. In general, there are expectant, medical and surgical options of treatment. 
Factors influencing the choice of treatment options include the type of the CSEP 
(Type I or II), haemodynamic stability, size of the pregnancy mass and gestational 
age, serum beta-hCG level, presence or absence of fetal cardiac activity, wish for 
future fertility, and availability of expertise (e.g. endoscopic surgery, interventional 
radiology) [8, 15–17]. A comprehensive review from UKEPSS demonstrates that 
the success rate of expectant, medical and surgical management were 43, 46 and 
96%, respectively [7]. The complication rates were 71% with expectant, 60% with 
medical and 36% with surgical management [7].
5.1 Expectant management
Even though expectant management of CSEP has been described [2, 3, 15, 18], 
the safety of continuing pregnancy is questionable. Caution must be exercised 
when choosing expectant management in cases of viable CSEP as it carries a 
significant risk of complications, including uterine rupture, severe haemorrhage 
and hysterectomy [4, 18, 19]. In a systematic review of a total of 56 cases (includ-
ing 44 cases with fetal cardiac activity) of CSEP managed expectantly, live births 
were achieved in 73% with a very high hysterectomy rate of 70% [18]. Women with 
viable CSEP and relatively favourable findings on imaging such as endogenic type, 
COS-2 on ultrasound and residual myometrial thickness of >5 mm on MRI may 
continue with the pregnancy if they have a strong desire to do so [19]. Women need 
to understand that expectant management of a viable CSEP carries a significant risk 
of severe haemorrhage, uterine rupture, hysterectomy and severe invasive placenta-
tion [7, 15, 19]. Expectant management can be considered in those with no fetal 
cardiac activity and with evidence of spontaneous resolution [18–20].
5.2 Medical management
5.2.1 Methotrexate
Methotrexate (MTX) can be administered locally or systemically as single or 
multiple doses. Primary systemic treatment with MTX is indicated in patients with 
non-viable CSEP. CSEPs have been shown to respond well to systemic administra-
tion of MTX (50 mg/m2), especially in those with low serum beta-hCG levels 
(<5000 mIU/ml). Like in tubal ectopic pregnancy, MTX is appropriate for a woman 
who is pain-free and hemodynamically stable with unruptured pregnancy of 
<8 weeks’ gestation. While a single dose treatment may be adequate for cases with 
low serum beta-hCG levels (<5000 mIU/ml), multiple doses may be necessary in 
those with high beta-hCG levels.
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Methotrexate can also be given directly into the gestational sac. Local MTX 
administration is preferable in cases with viable CSEP. Ramkrishna et al. have 
described their medical management protocol [21]. They use ultrasound guided 
intra-sac injection of 50 mg of MTX into the gestational sac using 18G chorionic 
villus sampling needle after aspirating the content of the sac. Prior injection of 2 ml 
(30 mmol/ml) KCL is used when fetal cardiac activity is present [21]. Additional 
dose(s) of systemic MTX is used for those cases with plateaued serum hCG level. 
The success rate of primary medical management (systemic/local) was 86% for 
CSEP in their study subjects [21].
There is a suggestion that direct injection of MTX into the sac achieves a high 
concentration locally and therefore interrupts the pregnancy more rapidly than 
a systemic administration of the drug [22]. The local injection can be done under 
ultrasound guidance (transabdominal or transvaginal), or direct vision through 
laparoscopy or hysteroscopy. A larger gauge needle is preferable to ensure better 
aspiration of the content of the gestational sac at the same time.
A high dose of intravenous MTX infusion, followed by oral folinic acid rescues, 
has also been used with a success rate of 85.7% [23].
5.2.2 Local embryocidal injection
Local injection of potassium chloride (or other embryocides- e.g. lignocaine [1]) 
can be used when there is fetal cardiac activity, or for selective embryocidal action 
in cases of heterotopic pregnancies [10, 24]. Similar to local MTX injection, this 
can be done under ultrasound guidance (transabdominal or transvaginal), or direct 
vision through laparoscopy or hysteroscopy followed by local or systemic MTX.
5.3 Surgical treatment
Several surgical treatment options are described.
5.3.1 Uterine curettage
By definition, the gestational mass in a CSEP is not actually within the uterine 
cavity. Therefore, not only the trophoblastic tissue is inaccessible by the curettage 
but also such attempts can potentially rupture the uterine scar leading to severe 
haemorrhage and cause more harm [4]. A recently published meta-analysis sug-
gested favourable outcomes (less blood loss, lower incidence of adverse events and 
shorter duration of hospital stay) following high-intensity focused ultrasound 
compared to uterine artery embolization before uterine curettage [25]. In a case-
control study, advanced gestational age, higher serum hCG level, bigger gestational 
sac diameter, thinner myometrial layer and significant peritrophoblastic perfusion 
were associated with excessive intra-operative haemorrhage ( ≥ 200 ml) during suc-
tion evacuation of CSEP [26].
5.3.2 Hysteroscopy or laparoscopy
Aspiration/resection of gestational contents can be accomplished either through 
operative hysteroscopy or laparoscopy [27–29]. The choice between laparoscopy 
and hysteroscopy depends on the type of CSEP. The hysteroscopic approach is more 
appropriate for CSEP that grows inward towards the uterine cavity (Type I), while 
a laparoscopy is more justified for a deeply implanted CSEP growing towards the 
abdominal cavity (type II).
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5.3.3 Laparotomy
Wedge resection of the gestation (hysterotomy) or hysterectomy should be 
considered in women who do not respond to conservative medical or surgical treat-
ments, present too late or if facilities and expertise for operative endoscopy are not 
available. Laparotomy is mandatory when uterine rupture is confirmed or strongly 
suspected.
5.4 Uterine artery embolization
Uterine artery embolization (UAE) in combination with other treatment 
modalities such as MTX, dilatation and curettage (D & C) or hysteroscopic resec-
tion has been used to treat CSEP [15, 30]. Catheterisation of the uterine arteries is 
carried out through a transfemoral approach under local anaesthesia. If emboliza-
tion is combined with a dose of MTX it is split between the two uterine arteries and 
infused via the arterial catheter. Finally, both uterine arteries are embolized with 
gelatin sponge particles or polyvinyl alcohol [15].
In a systematic review, UAE combined with D & C was highly effective with 
only 6.4% of cases needed additional treatment and severe complications (haemor-
rhage, hysterectomy) occurred in 3.4% of cases [15]. A combination of UAE, D 
& C and hysteroscopy also resulted in a high success rate of 95.4% and a very low 
complication rate of 1.2%. In women treated with a combination of UAE, D & C 
and MTX, additional treatment was needed in 31.4% because of treatment failure 
and hysterectomy rate was 2.8%. In comparison, between one-fourth to one-third 
of patient treated primarily with MTX required additional treatment [15].
5.5 Combination
In reality, most cases of CSEP are managed with a combination of both medical 
and surgical approaches [31]. Medical treatment - systemic or local, single agent or 
combined regiment can be used in conjunction with surgical treatment options. e.g.
• Ultrasound-guided sac aspiration, local MTX injection with or without local 
potassium chloride (KCL) [32]
• Local intra-sac KCL injection, systemic MTX injection [33, 34]
• Ultrasound/laparoscopic guide sac aspiration, local MTX injection, systemic 
MTX injection [16, 35]
• Systemic MTX, local KCL injection, laparoscopic resection [36]
• Intra-sac injection of KCL and MTX, systemic MTX, laparoscopic resection [37]
• Systemic MTX, dilatation and curettage [38, 39]
• UAE and intra-arterial MTX infusion [40]
Uterine artery embolization, bilateral uterine artery ligation, local vasopressin 
injection and intrauterine balloon tamponade have been used successfully as an 





Close follow up is essential to confirm complete resolution of the CSEP. Patients 
need serial serum beta-hCG measurements and pelvic ultrasound until the hCG 
level is undetectable, and the pregnancy mass disappears, which may take several 
weeks (see Figure 8) [34, 41]. In general, posttreatment weekly measurement 
of serum beta-hCG is required to confirm resolution [42, 43]. Patients who have 
undergone hysterectomy do not require hCG monitoring. Serial transvaginal colour 
flow Doppler is useful for monitoring the response to medical treatment. It is worth 
to note that uterine rupture and severe maternal haemorrhage can occur despite a 
satisfactory drop in serum hCG levels [1]. Continuation of fetal cardiac activity or 
growth of the sac with rising serum hCG concentration indicates failure of medical 
treatment. In a tubal ectopic pregnancy, a higher failure rate of medical treatment 
is associated with a gestational age of  ≥ 9 weeks, a fetal pole of >10 mm, presence 
of fetal cardiac activity and a serum beta-hCG concentration > 10,000 mIU/ml. 
However, no similar or consistent pattern could be observed for a CSEP.
6. Recurrence and management of subsequent pregnancies
The risk of recurrence in subsequent pregnancies is unknown. Uneventful 
viable intrauterine pregnancies have been reported after all modalities of conserva-
tive management of CSEP [34, 44]. Additionally, there are case reports whereby 
Figure 8. 
Changes in weekly serum beta-hCG levels of four patients with CSEP before and after the medical treatment. 
The values on the curve represent the beta-hCG measurements at each given week. MTX = methotrexate; 
LCV = Leucovorin; KCl = potassium chloride [42].
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patients had one or more episodes of recurrence of CSEP [44–46]. Owing to insuf-
ficient data, patients should be counselled about this uncertain risk of recurrence, 
and like patients with other types of ectopic pregnancies, they should be advised to 
avail of an early ultrasound examination in subsequent pregnancies to localise the 
pregnancy. Likewise, no reliable statistics exist on the safe interval between suc-
cessfully treated CSEP and subsequent pregnancy. In the absence of other obstetric 
indication for repeat caesarean delivery, women who are pregnant following suc-
cessful treatment of CSEP can consider delivering vaginally.
7. Conclusion
CSEP is a rare form of ectopic pregnancy but potentially associated with severe 
maternal complications. The incidence of CSEP is rising owing to the rise in caesar-
ean delivery rate worldwide and widespread use of imaging in early gestation. Little 
is known about its exact mechanism and natural history. Ultrasonography with 
colour flow Doppler yields a high diagnostic accuracy. Recommendations of treat-
ment options for CSEP are based on pieces of evidence from case reports and small 
case series. Therefore, treatment is individualised according to clinical presentation, 
availability of treatment options and expertise as well as the wish of the woman for 
future fertility.
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A Minimally Invasive Hemostatic 
Strategy for Cesarean Scar 
Pregnancy and Cervical 
Pregnancy
Satoru Takeda, Jun Takeda, Takashi Yorifuji 
and Taro Koshiishi
Abstract
Cesarean scar pregnancy (CSP) and cervical pregnancy are categorized as 
non-tubal ectopic pregnancy, because these are associated with a high burden of 
maternal and fetal morbidity including early uterine rupture, prevalence of pla-
centa previa accrete spectrum, massive hemorrhage, and hysterectomy. Although 
management methods vary according to the week of gestation, recent reviews 
and reports support an interventional or a combination of surgical and medical 
approaches for treatment of unruptured CSP and cervical pregnancy rather than 
medical approach alone. In cases of massive hemorrhage, pressure hemostasis 
using balloon tamponade should first be performed. If such hemostasis proves to be 
ineffective, surgical excision or transcatheter arterial embolization (TAE) should be 
selected next. TAE reportedly achieves a high hemostasis rate. However, complica-
tions such as subsequent endometrial hypoplasia, menstruation disorder, infertility, 
placenta accreta, and uterine rupture have been reported, even in cases that have 
undergone successful hemostasis with TAE using an absorbable embolus. Recently, 
a minimally invasive hemostatic strategy in obstetrics, which aims to preserve 
uterine function and enhance the safety of subsequent pregnancies, has been devel-
oped. Therefore, we should reconsider uterus-preserving hemostatic strategies for 
critical hemorrhage and management of non-tubal ectopic pregnancy under these 
circumstances by using safe and minimally invasive treatment modalities.
Keywords: arterial embolization, balloon tamponade, cervical pregnancy, cesarean 
scar pregnancy, massive hemorrhage, methotrexate
1. Introduction
Cesarean scar pregnancy (CSP) and cervical pregnancy are categorized as  
non-tubal ectopic pregnancy and may cause massive hemorrhage, uterine rupture, 
and hysterectomy. In CSP and cervical pregnancy cases, it is possible that the 
location of the gestational sac (GS) may lead to a misdiagnosis of abortion. Another 
possibility is a failure to detect CSP until massive hemorrhage occurs following 
curettage. Therefore, diagnosis and treatment strategies in early pregnancy are 
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important. Delay in the diagnosis and management may lead to massive hemor-
rhage, which is difficult to control. This complication can be treated with life-saving 
hysterectomy or uterine arterial embolization, which requires massive blood 
transfusion [1]. Management based on the pathophysiology of the implantation 
site that has a rich blood supply is essential. Although management methods vary 
according to the week of gestation, typical strategies include surgical treatment, 
administration of drugs such as methotrexate (MTX), and combinations of these 
treatments. In addition, hemostatic procedures vary and include balloon tampon-
ade, transcatheter arterial embolization (TAE), and surgical treatments such as 
curettage, evacuation, wedge resection, and hystero-resectoscopy, for control and 
prevention of hemorrhage.
In the field of obstetrics, TAE is known to be highly effective in controlling 
uterine hemorrhage and hematoma. This procedure reportedly achieves a high 
hemostasis rate, and thus, the frequency of hysterectomy has sharply decreased [2, 3]. 
However, complications such as subsequent endometrial hypoplasia, menstruation 
disorder, infertility, pregnancy loss, placenta accreta, and uterine rupture have been 
reported, even in cases that have undergone successful hemostasis with TAE using 
an absorbable embolus [4–6]. Recently, a minimally invasive hemostatic strategy 
in obstetrics, which aims to preserve uterine function and enhance the safety of 
subsequent pregnancies, has been developed [2, 7]. Therefore, we should reconsider 
uterus-preserving hemostatic strategies for critical hemorrhage and management of 
non-tubal ectopic pregnancy under these circumstances by using safe and minimally 
invasive treatment modalities. We herein discuss how to select the optimal hemostatic 
strategy and its management based on literatures and our experiences of non-tubal 
ectopic pregnancy.
2. Pathology and frequency
When the uterus is observed by ultrasonography more than 3 months after 
cesarean section (by transverse incision in the lower uterine segment), endometrial 
defect and defect or thinning of the myometrium at the site of the uterine incision are 
recognized as a triangular echo-free space at a frequency of approximately 50% [8].
Implantation at this site is considered to be the origin of CSP [9]. Delay in the 
diagnosis and treatment of CSP may cause uterine rupture and massive hemor-
rhage, resulting in hysterectomy or massive blood transfusion in serious cases. 
In the case of CSP, the site of villous anchoring is the isthmus of the uterus or the 
cervical canal where the endometrium and cervical mucosa are thinner than in the 
uterine body. Therefore, chorionic villi are likely to penetrate into the myometrium, 
inducing conditions similar to placenta increta and placenta percreta. The clinical 
picture and course vary according to the site of villous anchoring [1].
It has been reported that the frequency of CSP is 0.04–0.19% among all preg-
nancies, 0.15% among those with prior cesarean section, and 6.1% among ectopic 
pregnancies associated with prior cesarean section [10]. Recently, a national cohort 
study showed that the estimated incidence of CSP was 0.015% in the UK [11]. It 
is speculated that the incidence of CSP may increase in the future as the rate of 
cesarean section rises.
3. Diagnosis
Chorionic villi are smaller and penetrate less deeply into the myometrium 
in the early stages of pregnancy. Therefore, they are considered to be easier 
81
A Minimally Invasive Hemostatic Strategy for Cesarean Scar Pregnancy and Cervical Pregnancy
DOI: http://dx.doi.org/10.5772/intechopen.89666
to remove, and it is also believed that the uterus is more likely to be preserved, 
in early pregnancy. After 9 or 10 weeks of gestation, the placenta invades the 
myometrium more deeply, and there is abundant blood flow into the placental 
bed, increasing the risk of massive hemorrhage. The risk of uterine rupture and 
placental invasion into the bladder is also increased. When accurately diagnosing 
CSP, it is important to observe the boundary area between the uterine body and the 
cervix in early pregnancy. The decisive factors in making a diagnosis of CSP are the 
presence of a gestational sac (GS) in that area and villous adhesion to the anterior 
wall (Table 1) [1, 8, 12–14]. Transvaginal ultrasonography is useful for identify-
ing the implantation of chorion frondosum in the scar area (Table 2, Figure 1); 
the reported sensitivity of this modality is 84.6% [14]. The combined use of color 
Doppler ultrasonography allows clinicians to estimate the viability of gestational 
tissue [10, 13], providing useful information for selection of the most appropriate 
1. Diagnosis using transvaginal ultrasonography and contrast-enhanced magnetic resonance imaging
• Evaluation of the implantation site
• Evaluation of blood flow around the villous tissue invading the scar area (Figures 2 and 3)
• Evaluation of thinning of the scar area, presence/absence of continuity of the myometrium, and 
presence/absence of villous invasion into the bladder
2. Evaluation of the viability of the villi
• Blood hCG level
• Color Doppler ultrasonography
3. Presence/absence of vaginal bleeding
Table 1. 
Key points in diagnosing cesarean scar pregnancy.
1. There is no gestational sac in the uterine cavity.
2. In the sagittal view of the uterus, thinning and a wedge-shaped defect of the anterior wall myometrium 
are detectable in the wound area of the previous cesarean section, and the gestational sac is present in 
that area.
3. Villi (high echoic area) are observed on the bladder side of the anterior wall of the uterus.
4. Color Doppler ultrasonography shows blood flow in the gestational sac and areas around the scar.
Table 2. 
Ultrasonographic findings of cesarean scar pregnancy.
Figure 1. 
Findings of transvaginal color Doppler ultrasonography (produced with permission from [1]). The gestational 
sac accompanied by blood flow in the surrounding tissues is seen near the scar of the previous cesarean section 
(endogenic type). There is no gestational sac in the uterine cavity.
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Findings of T2-weighted magnetic resonance imaging (produced with permission from [1]). This is a case 
of cesarean scar pregnancy with positive fetal heartbeats at 9 weeks of gestation. The chorion frondosum is 
bounded on the bladder and extends into the thinned myometrium of the scar.
treatment method. The descending GS in the event of an inevitable abortion and 
GS in CSP can be distinguished by the presence/absence of blood flow in the 
villous area [1]. Magnetic resonance imaging (MRI) is also useful for determin-
ing the thickness of the myometrium in the wound site and the depth of villous 
invasion into the bladder, as well as for identifying nutrient vessels (Figure 2) [1]. 
When invasion into the bladder is suspected in the middle stages of pregnancy or 
thereafter, confirmation by cystoscopy is required.
4. Management of cesarean scar pregnancy (CSP)
Although expectant management of CSP with positive fetal heart activity 
may still be a choice [11, 15], termination of CSP and cervical pregnancy should 
be offered to these women and families as one of the therapeutic options. The 
basic policy for the management of CSP and cervical pregnancy is termination of 
pregnancy and preservation of the uterus, because these are associated with a high 
burden of maternal and fetal morbidity including complicated miscarriage, early 
uterine rupture, prevalence of placenta previa accreta spectrum, massive hemor-
rhage, hysterectomy, maternal and fetal death, etc. The method of treatment should 
be selected according to the gestational week, presence/absence of fetal heart beats, 
the blood hCG level, and abundance of the blood supply adjacent to villi or the 
gestational sac.
Chemotherapeutic drugs such as methotrexate (MTX) are administered sys-
temically or locally, with or without potassium chloride (KCl), to avoid surgical 
treatment for CSP [16–19]. However, achieving the desired healing with drug treat-
ment alone can be time-consuming, and hemorrhage or infection may occur con-
comitantly during the process of treatment. MTX treatment alone as the first-line 
therapy showed low success rate. In addition, adverse reactions to drugs, such as 
stomatitis and leucocytopenia, may also occur. Recent reviews and reports support 
an interventional or a combination of surgical and medical approaches rather than 
medical approach alone [20–24]. In a national cohort study, surgical management 
appears to be associated with a high success rate, low complication rate, and short 
posttreatment follow-up [11].
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If there is a CSP mass protruded toward outside of the uterus (exogenic type) 
(Figure 3), or a mass attached to defect or thinning (<2 mm) of lower uterine 
myometrium, the lesion may be removed laparoscopically or by laparotomy and 
then sutured [25–27], because these types of CSPs could be complicated with 
uterine rupture and bleeding early in pregnancy. But evidence-based treatment still 
remains unclear in these cases.
4.1 Surgical approach
4.1.1 Curettage
Curettage or evacuation allows preservation of fertility, can be performed 
under intravenous or spinal anesthesia, and is minimally invasive [1, 18, 20, 22–25, 
27, 28]. Curettage or evacuation may be performed under ultrasound guide after 
administration of MTX and/or KCl. In addition, it requires only a short period of 
hospitalization in successful cases. On the other hand, there is the risk of massive 
hemorrhage or uterine perforation during surgery as well as complications such as 
uterine rupture and residual tissue. Additional treatment such as balloon compres-
sion hemostasis or TAE may be required to deal with bleeding [27].
It has been reported that massive hemorrhage, difficult to control, occurred 
after curettage in patients who had a low hCG level but had abundant blood flows 
in the lesion, prompting caution in the management of such patients [1]. This is 
because neovascularity may persist even when the hCG level is decreased after villi 
have been devitalized by chemotherapy or dilation and curettage (D&C).
4.1.2 Other surgical procedures
In patients with massive hemorrhage after D&C or with CSP diagnosed after 
massive hemorrhage, priority is given to hemostasis. Therefore, CSP is removed 
by transvaginal resection [26] or laparotomic resection [29], and uterine artery 
ligation [30], cervical suture [31], or TAE is performed. When deep villous invasion 
is predicted in view of the gestational week, the fertilized ovum should be removed 
by abdominal resection and suture in cases with wound rupture or dehiscence or 
subserous protrusion of the lesion.
Along with recent advancements in laparoscopic techniques, cases undergo-
ing less invasive laparoscopic or hysteroscopic resection of the lesion have been 
Figure 3. 
Protrusion of the cesarean scar pregnancy lesion toward the bladder (produced with permission from [1]). The 
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hemorrhage or uterine perforation during surgery as well as complications such as 
uterine rupture and residual tissue. Additional treatment such as balloon compres-
sion hemostasis or TAE may be required to deal with bleeding [27].
It has been reported that massive hemorrhage, difficult to control, occurred 
after curettage in patients who had a low hCG level but had abundant blood flows 
in the lesion, prompting caution in the management of such patients [1]. This is 
because neovascularity may persist even when the hCG level is decreased after villi 
have been devitalized by chemotherapy or dilation and curettage (D&C).
4.1.2 Other surgical procedures
In patients with massive hemorrhage after D&C or with CSP diagnosed after 
massive hemorrhage, priority is given to hemostasis. Therefore, CSP is removed 
by transvaginal resection [26] or laparotomic resection [29], and uterine artery 
ligation [30], cervical suture [31], or TAE is performed. When deep villous invasion 
is predicted in view of the gestational week, the fertilized ovum should be removed 
by abdominal resection and suture in cases with wound rupture or dehiscence or 
subserous protrusion of the lesion.
Along with recent advancements in laparoscopic techniques, cases undergo-
ing less invasive laparoscopic or hysteroscopic resection of the lesion have been 
Figure 3. 
Protrusion of the cesarean scar pregnancy lesion toward the bladder (produced with permission from [1]). The 




reported [14, 18, 20, 22, 23]. Surgical resection of the lesion and wound repair 
(wedge resection and repair) is reportedly less likely to require additional treatment 
and is highly effective for the prevention of recurrence. However, at present, data 
on the scientific basis of treatment and recurrence of CSP are lacking.
5. Management of cervical pregnancy
Several case reports and literatures support surgical therapy alone or in com-
bination with MTX and/or mifepristone rather than medical therapy alone for 
treatment of cervical pregnancy as the same as those of CSP [21, 32–35]. Uterine 
artery embolization for treatment and prevention of hemorrhage during curettage 
or evacuation is also effective to preserve the uterus [36–39].
To control bleeding during curettage and evacuation, hemostatic techniques such 
as hemostatic clamps or cervical cerclage to block cervical blood supply and balloon 
tamponade by Foley catheter or a cervical ripening balloon were reported [40–44]. 
Recently, more minimally invasive total hysteroscopic treatment for cervical preg-
nancy and also conservative treatment, using a cervical ripening double-balloon cath-
eter alone, were reported [44, 45]. These seem to be an effective, safe, and minimally 
invasive and single promising treatment without any medical and surgical treatment. 
These individual managements have to be validated on a large patient population.
6. Control of bleeding
Massive hemorrhage reportedly occurs in some cases after evacuation of the uterus 
D&C has on occasion been performed without an accurate diagnosis. In such cases, 
balloon tamponade, TAE, and surgical treatment are effective management strategies. 
If balloon tamponade or TAE is successful in controlling hemorrhage, conservative 
treatment is also a feasible option. If bleeding is under control, there are several pos-
sible treatment options for preservation of the uterus. These options have their own 
advantages and disadvantages, and selection of the most appropriate treatment varies 
according to the facility and the time of day. Therefore, the treatments should be tai-
lored to individual patients based on the situation and their wishes regarding fertility.
In cases experiencing massive hemorrhage, pressure hemostasis using balloon 
tamponade should first be performed. If such hemostasis proves to be ineffective, 
surgical excision or TAE should be selected next. When performing cesarean scar 
resection, the right and left uterine arteries are to be clamped.
6.1 Balloon tamponade
This is a hemostatic technique used for overall uterine hemorrhage in the 
puerperal period including atonic bleeding, incomplete cervical laceration, crush 
syndrome, and bleeding from the separation surface of placenta previa. Balloon 
tamponade is also effective and useful for uterine hemorrhage from CSP and cervi-
cal pregnancy (Figure 4) [46]. In an emergency, insertion and placement of the 
balloon are technically easy and can be performed expeditiously; this technique is 
simple and minimally invasive. It is also possible to determine within a short period 
of time whether hemostasis can be achieved by tamponade alone (tamponade test) 
[47]. Even when switching to TAE is necessary, the radiology department does not 
need to be consulted, and the amount of bleeding during preparation for TAE can 
be decreased. This technique is also useful for temporary hemostasis when a patient 
must be transferred to an advanced medical facility.
85
A Minimally Invasive Hemostatic Strategy for Cesarean Scar Pregnancy and Cervical Pregnancy
DOI: http://dx.doi.org/10.5772/intechopen.89666
The balloon should be gently pulled to confirm that it would not easily prolapse 
into the vaginal cavity and that bleeding from the cervical os has been halted. Long 
gauze should be retained in the vaginal cavity to prevent prolapse of the balloon. 
A urethral catheter should be placed in the bladder to prevent urinary retention. If 
there is no massive hemorrhage that would surpass the absorption capacity of the 
retained gauze, the balloon is to be removed in 24–48 h. The presence of uncontrol-
lable bleeding immediately after the insertion should be deemed a negative result 
of the tamponade test, and the procedure is then switched to TAE or laparotomic 
hemostasis without hesitation.
6.2 Transcatheter arterial embolization (TAE)
If bleeding is not controllable by the procedures described above, arterial 
embolization should be performed without hesitation. TAE is advantageous in 
that it allows embolization of not only the artery in question but also anastomotic 
branches while confirming the bleeding point. The rates of hemostasis achievement 
are reportedly in the range of 89–97% [1, 3].
It is known that, in CSP cases, abnormal growth and anastomosis of inflow ves-
sels occur when the shaggy chorion grows not in the uterine body but in the vicinity 
of the site of entry into the uterine artery; this causes pathological features different 
from those associated with the uterine blood flow distribution in normal pregnancy. 
Therefore, unlike the conventional uterine arterial blood flow, vascular anastomo-
ses are not restricted to those derived from the internal iliac artery. Various anasto-
moses involving the external iliac artery, lumbar artery, inferior mesenteric artery, 
sacral artery, superior gluteal artery upstream of the internal iliac artery system, 
and the external iliac artery system are observed.
Figure 4. 
Compression hemostasis by balloon tamponade (produced with permission from [1]). (A) In a case with 
cesarean scar pregnancy, after dilation and curettage, a hematoma (pooling of blood) was observed in the 
wound area, which prominently showed blood spurting out into its cavity. This case is the same as the one at 
9 weeks of gestation in Figure 2. (B) The blood flow disappears after inflation with a Minimetro®. A balloon 
should be inserted from the uterine os guided by ultrasound. Physiological saline (20–30 mL) is then infused 
into the balloon. The balloon should be gently pulled to confirm that it will not easily prolapse into the vaginal 
cavity and that bleeding from the uterine os has been halted. Recently, the bleeding point after dilation and 
curettage could be precisely detected by contrast-enhanced ultrasonography, and a balloon could be inflated at 
the bleeding point until bleeding stops.
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Rebleeding may occur due to recanalization or insufficient embolization, and it 
is difficult to control bleeding when there is abundant blood flow from the external 
iliac artery region. Therefore, attention should be paid to the patient’s general 
condition after implementation of TAE. In most cases, bleeding can be controlled 
by TAE. If TAE is ineffective, or if bleeding persists, it is recommended that the 
aforementioned balloon tamponade be added to the management. Gelatin sponge 
is usually used as a temporary solid embolic substance lasting for several days to 
about 2 weeks. In addition, metal coils as permanent solid embolic substances and 
N-butyl-2-cyanoacrylate as a permanent liquid embolic substance are also available. 
The incidence rate of adverse reactions is 6–7.8%. Fever is the most frequent untow-
ard effect. Other adverse reactions include endometrial necrosis, adhesion, myome-
trial necrosis, ovarian insufficiency, bladder necrosis, gluteal muscle necrosis, and 
pelvic suppuration [1, 3]. Pregnancy after TAE for postpartum hemorrhage may 
be associated with increased risk of obstetric hemorrhage due to placenta accreta 
spectrum. Therefore, precautions in perinatal management are required in manag-
ing the subsequent pregnancy.
6.3 Surgical hemostasis
If bleeding is uncontrollable employing the procedures described above, laparo-
tomic hemostasis should be selected as the last resort. Since TAE became available, 
application of this technique has mostly been limited to cases of uterine rupture in 
the affected area. Hysterectomy, ligation of the uterine artery, or wedge resection 
and repair of the lesion in the scar should be performed. Prompt selection of the 
optimal procedure, taking into consideration the amount of bleeding, size of the 
lesion, whether the patient desires fertility preservation, etc., is necessary. Patients 
with indications for these procedures often have concomitant obstetric coagulopa-
thy. Therefore, sufficient supplementation of coagulation factors is also essential 
prior to surgery [2, 7].
6.4 Treatment of coagulopathy
In cases of massive hemorrhage, patients must be kept in good systemic condi-
tion, and local hemostasis must be achieved while paying attention to the possible 
occurrence of coagulopathy under monitoring of fibrinogen levels as point-of-care 
testing in order to perform early diagnosis and treatment of coagulopathy [7]. When 
coagulopathy is present, local hemostasis, such as balloon tamponade, surgical 
sutures, and TAE, is difficult to achieve because of hemorrhagic tendency. In these 
cases of coagulopathy, the blood fibrinogen level is often <100 mg/dL. Therefore, 
the treatment of coagulopathy should be performed by combined administration 
of concentrated coagulation factors (fibrinogen concentrate and cryoprecipitate) 
and fresh-frozen plasma promptly to obtain a blood fibrinogen level of at least 
150–200 mg/dL [7, 48]. If coagulopathy is eliminated, the conventional hemostatic 
procedures become effective.
7.  A minimally invasive hemostatic strategy in CSP and cervical 
pregnancy
Curettage alone is reportedly not a suitable first-choice procedure because using 
curettage only may lead to serious complications such as massive hemorrhage or 
uterine rupture, necessitating additional treatment in 76.2% (16/21) of patients 
[1]. On the other hand, the methotrexate (MTX) monotherapy is time-consuming 
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in terms of achieving cure and may be accompanied by hemorrhage or infection. 
Reduction of the chorionic tissue by MTX therapy to decrease blood flow, followed 
by curettage or laparotomy, rather than MTX or curettage alone, achieves a higher 
cure rate and is associated with fewer complications such as hemorrhage, infection, 
and sepsis.
For the management of CSP and cervical pregnancy in the first trimester, we 
first perform ultrasonography to confirm the implantation site of the gestational 
sac, observe the status and thickness of the myometrium in surrounding areas and 
the presence/absence of fetal heart beats, and determine the gestational week. At 
the same time, we measure the blood hCG level and evaluate blood flow around the 
gestational sac by Doppler ultrasonography. Changes in the blood hCG levels and 
the status of blood flow are useful for judging the viability of chorionic villi and the 
efficacy of estimating chemotherapy. If there is abundant blood flow in the myome-
trium as well as in the tissues surrounding the gestational sac, villous invasion site 
on the myometrium is suspected. In such cases, implementation of D&C alone is 
expected to cause massive hemorrhage.
When there are fetal heart beats, potassium chloride (KCl) is administered 
directly to the fetus to cause cessation of the heart beating. MTX is administered 
systemically (1 mg/kg body weight) or by local injection to the villous area at the 
same time. Subsequently, MTX is administered systemically every 7–10 days. In 
patients with high blood levels of hCG, MTX therapy used to be performed to 
decrease the hCG level to a target of 20,000 mIU/mL, or even lower, followed by 
TAE and curettage. The rates of blood transfusion and/or blood loss of >2500 mL 
in these combined treatment (MTX + TAE + D&C) were significantly decreased, 
compared with those in D&C alone, 9.5 and 83.3% respectively.
The rate of additional surgical treatment, such as wedge resection or hysterec-
tomy, in combined treatment, was none, compared with D&C alone, 0 and 50.0%, 
respectively. There were no complications such as uterine rupture, postoperative 
infections, menstrual abnormalities, and ovarian dysfunction in D&C alone and 
combined treatment. These combined treatments yielded satisfactory results with 
a decreased volume of blood loss, no additional surgical treatment, and a high cure 
rate, compared with D&C alone (Figure 5, Tables 3 and 4).
Currently, prophylactic TAE before D&C is avoided whenever possible, with the 
aim of preventing short-term complications and uterine rupture in the subsequent 
pregnancy, and also shortening hospital stay. A target blood hCG levels after MTX 
is also changed to <40,000 mIU/mL for adverse effects of MTX. Then, ultrasound-
guided D&C to evacuate the gestational sac is performed a week later after MTX 
therapy. Bleeding point during D&C could be found by contrast-enhanced ultraso-
nography, and a cervical ripening miniballoon (Minimetro®) could be inserted at 
the bleeding point and inflated until bleeding stops [46, 49]. If bleeding continues, 
TAE or laparoscopic wedge resection would be performed as soon as possible. Nine 
patients with CSP (6–12 weeks gestation) and one (7 weeks gestation) with cervi-
cal pregnancy were treated under new management. Seven cases were successfully 
treated with D&C and balloon tamponade after MTX. Additional treatments were 
needed in three cases for bleeding. This combined therapy resulted in all complete 
cure and no additional surgical therapy without complications.
Moreover, if early detection of CSP is possible, more minimally invasive treat-
ments might be another option of treatment such as double balloon conservative 
therapy or hysteroscopic resection without MTX therapy. We also experienced one 
case with CSP to be successfully treated after cessation of fetal heart beats by local 
injection of KCl. She selected conservative therapy without chemotherapy and 
surgical therapy and then was just followed up in outpatient clinic. It took 6 months 
to be cured completely, but there were no complications and no bleeding. Even in 
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Characteristic D&C alone 
(n:6)
MTX + TAE + D&C (n:21) P-value
Age (years) 34.5 + 3.0 34.0 + 5.8 0.84
(32–39) (23–42)
Number of previous CS (n) 1.5 + 0.8 1.3 + 0.6 0.47
(1–3) (1–3)
Gestational age at diagnosis (weeks) 7.8 + 2.4 6.3 + 1.1 0.19
(6–12) (5–8)
Blood hCG levels at diagnosis (mIU/mL) 17,551.3+ 37,876.1+ 0.18
20,483.0 33,816.3
Blood hCG levels at D&C (mIU/mL) 15,360.8+ 17,840.5+ 0.78
20,344.9 19,111.9
There are no significant differences in characteristics between D&C alone and combined treatment.
Table 3. 
Comparison of background between cases with dilation and curettage (D&C) alone and those with 
methotrexate + transcatheter arterial embolization + D&C.
Figure 5. 
Treatment results of cesarean scar pregnancy with fetal heart beats under uterus-preserving management. 
Thirty patients diagnosed with cesarean scar pregnancy with positive fetal heartbeat in the first trimester were 
treated at Saitama Medical Center and Juntendo University Hospital from 1998 to 2010. The average maternal 
age was 33.3 ± 5.8 years (mean ± SD), and average gestational age on admission was 6.6 ± 1.5 weeks of gestation. 
The average hCG level on admission was 29,534 ± 26,284 mIU/mL, and its level on dilation and curettage 
was 19,995 ± 24,765 mIU/mL. Twenty-one patients were treated under our uterus-preserving management 
policy and six patients were transferred to our hospital due to uncontrollable hemorrhage after dilation and 
curettage. This management strategy yielded satisfactory results with a decreased volume of blood loss and a 
high cure rate.
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cases with placenta previa on cesarean delivery scar, who were managed to leave the 
placenta in situ for placenta accreta spectrum disorders after cesarean section near 
term (median 36 weeks gestation; range 28–38 weeks gestation) in order to preserve 
the uterus without hysterectomy, the conservative therapy was successful in 25 
(69.4%) cases without any additional surgery [50]. Placental resorption occurred 
postpartum (median 89 days; range 6–510 days). Hysterectomy was performed for 
the other 11 cases, primarily owing to hemorrhage and/or infection. Considering 
smaller uterine blood supply and amount of gestational tissues in the first trimester 
than those in near term, conservative management after cessation of fetal heart 
beats in cesarean scar pregnancy may have higher success rate, if possible, with 
close postpartum follow-up for at least several months.
8. Conclusion
The basic policy for the management of non-tubal ectopic pregnancy, such as 
CSP and cervical pregnancy, is termination of pregnancy and preservation of the 
uterus, and the method of treatment should be selected according to the gestational 
week, presence/absence of fetal heart beats, the blood hCG level, and abundance of 
the blood supply adjacent to villi or the gestational sac. Recent reviews and reports 
support an interventional or a combination of surgical and medical approaches for 
treatment of unruptured CSP and cervical pregnancy rather than medical approach 
alone. In a national cohort study, surgical management appears to be associated 
with a high success rate, low complication rate, and short posttreatment follow-up.
Massive hemorrhage reportedly occurs in some cases with spontaneous rupture 
or after evacuation of the uterus without an accurate diagnosis. In cases experienc-
ing massive hemorrhage, pressure hemostasis using balloon tamponade should first 
be performed. If such hemostasis proves to be ineffective, surgical excision or TAE 
should be selected next. If balloon tamponade or TAE is successful in controlling 
hemorrhage, conservative treatment is also a feasible option. In cases with coagu-
lopathy, the blood fibrinogen level is often <100 mg/dL. Therefore, the treatment 
of coagulopathy should be performed by combined administration of concentrated 
coagulation factors (fibrinogen concentrate and cryoprecipitate) and fresh-frozen 
plasma promptly to obtain a blood fibrinogen level of at least 150–200 mg/dL.
Recently, a minimally invasive hemostatic strategy in obstetrics, which aims to 
preserve uterine function and enhance the safety of subsequent pregnancies, has 
been developed. Therefore, we should reconsider uterus-preserving hemostatic 
D&C alone 
(n:6)
MTX + TAE + D&C (n:21) P-value
Blood transfusion/>2500 mL blood loss 83.3% 9.5% 0.001
(5/6) (2/21)
Wedge resection/hysterectomy 50.0% 0% 0.007
(3/6) (0/21)
Hospital stay (days) 15.5 + 10.4 9.6 + 8.4 0.163
Combined procedures (MTX + TAE + D&C) yielded satisfactory results with a decreased volume of blood loss, no 
additional surgical treatment, and a high cure rate, compared with D&C alone.
Table 4. 
Comparison of outcome and additional treatment between D&C alone and methotrexate + transcatheter 
arterial embolization + dilation and curettage (D&C).
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Table 3. 
Comparison of background between cases with dilation and curettage (D&C) alone and those with 
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Figure 5. 
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be performed. If such hemostasis proves to be ineffective, surgical excision or TAE 
should be selected next. If balloon tamponade or TAE is successful in controlling 
hemorrhage, conservative treatment is also a feasible option. In cases with coagu-
lopathy, the blood fibrinogen level is often <100 mg/dL. Therefore, the treatment 
of coagulopathy should be performed by combined administration of concentrated 
coagulation factors (fibrinogen concentrate and cryoprecipitate) and fresh-frozen 
plasma promptly to obtain a blood fibrinogen level of at least 150–200 mg/dL.
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strategies for critical hemorrhage and management of non-tubal ectopic pregnancy 
under these circumstances by using safe and minimally invasive treatment modali-
ties. Moreover, if early detection of CSP is possible, more minimally invasive treat-
ment might be another option of treatment such as double balloon conservative 
therapy or hysteroscopic resection without chemotherapy. Conservative therapy 
without chemotherapy and surgical therapy may be the other option. They were just 
followed up closely in outpatient clinic after cessation of fetal heart beats by local 
injection of KCl.
The optimal treatment of CSP and cervical pregnancy is still unclear at present. 
Further evaluation of several therapies and hemostatic techniques by treating a 
large number of patients is necessary.
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An ectopic pregnancy implanted between the leaves of the broad ligament is a 
challenge to diagnose and manage. It can be found in almost any week of pregnancy, 
and it can present with a great spectrum of symptoms. This makes it necessary 
for the clinician to keep a high level of alertness and suspicion for this uncom-
mon diagnosis and to be prepared when treating any ectopic pregnancy with poor 
response to medical treatment. The broad ligament surrounds a number of ana-
tomical structures, structures necessary to be preserved when removing the ectopic 
pregnancy. This can be a challenge for the surgeon, especially when the patient 
presents with severe symptoms and the pregnancy is advanced. In these cases, even 
hysterectomies have been reported, a severe operation especially when the patient 
is young and without having completed her family planning. Finally, in the last 
three decades with the increasing widespread of laparoscopy and the added experi-
ence, there is a growing effort to manage these ectopic pregnancies with minimally 
invasive procedures, offering the patient a faster recovery, minimum blood loss, and 
lower surgical morbidity.
Keywords: broad ligament, ectopic pregnancy, abdominal pain, laparotomy, 
laparoscopy, hysterectomy
1. Introduction
One of the rarest places of an ectopic pregnancy to be implanted is between the 
leaves of the broad ligament. Loschge in 1816 made the first known report of a broad 
ligament pregnancy [1], while Champion et al. in 1938 published a large series of 62 
cases [2]. Kennedy in 1925, after recording one broad ligament pregnancy among 613 
ectopic cases, calculated the incidence of intraligamentary pregnancy as 1 for every 
183,900 pregnancies [3]. Even today when the medical literature is so extended and 
continuing, the exact incidence of this rare type of ectopic pregnancy is difficult 
to be exactly calculated. The extensive use of assisted reproductive technology has 
made even more difficult tracking every case. The rarity of ectopic pregnancies in 
the broad ligament makes it challenging for the clinician to diagnose, and it needs a 
high index of suspicion. In most of cases the diagnosis is done during an operation 
for treatment of a presumed ruptured tubal pregnancy. Despite the fact that most 
cases are diagnosed in the first trimester of pregnancy, there are a few cases reported 
that the diagnosis was not made until the third trimester and the final outcome was a 
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live birth. The rarity of these cases also makes it impossible to find extensive series of 
patients so as to determine the best treatment, making the clinician rely on previous 
case reports and the methods used in other treated cases.
2. Anatomy
The broad ligament of the uterus is a double-layer fold of peritoneum (anterior 
and posterior leaves) extending from each side of the uterus to the lateral pelvic walls 
and the pelvic floor. It covers the lateral uterine corpus and the upper cervix as well. 
The structures within the broad ligament (uterine tubes, ovarian artery, uterine 
artery, ovarian ligament, round ligament of the uterus, suspensory ligament of the 
ovary, ovary) are considered retroperitoneal. The broad ligament itself is composed of 
visceral and parietal peritonea that contain smooth muscle and connective tissue [4, 5].
3. Pathophysiology
The way the trophoblast can be implanted retroperitoneally is still not clear. 
Broad ligament pregnancies are classified as abdominal ectopic pregnancies and can 
be further classified as primary or secondary. Many of them are considered to have 
started as a tubal or ovarian pregnancy, which later ruptured intraperitoneally and 
was implanted again in another location [6]. Studdiford in 1942 [7] suggested three 
criteria, later modified by Friedrich and Rankin [8], for the diagnosis of a primary 
peritoneal pregnancy, (i) normal tube and ovaries with no evidence of recent or 
remote surgery, (ii) absence of any uteroperitoneal fistula, and (iii) the presence 
of a pregnancy related exclusively to the peritoneal surface and young enough to 
eliminate the possibility of secondary implantation following a primary nidation in 
the tube.
Sotus in 1977, in a case report of a retroperitoneal ectopic pregnancy, hypothe-
sized that an ectopic trophoblast could invade and penetrate the peritoneum, which 
soon thereafter covered the gestational tissues [9].
Another possible way for retroperitoneal implantation is during the embryo 
transfer in IVF, with uterine perforation and direct retroperitoneal placement. The 
arguments against this proposal are based on the softness and the flexibility of the 
catheters used for embryo transfer [7]. Another argument against this mechanism 
that has been reported is a broad ligament pregnancy after an ultrasound-guided 
embryo transfer [11].
The above proposals cannot explain how a broad ligament pregnancy can occur 
in a patient with bilateral salpingectomy. The possibility of a microscopic fistulous 
tract through which the transferred embryos entered the abdominal cavity has also 
been proposed by Fisch et al. in 1996 [10]. Apantaku et al., also in 1996, proposed 
the possibility of recanalization of a fallopian tube stump in a patient with bilateral 
salpingectomy [11].
Fisch et al. made another proposal trying to explain a reported broad ligament preg-
nancy. They suggested that the spermatozoa could enter the abdominal cavity through 
a cornual fistulous tract and fertilize an oocyte already migrated there. This proposal 
was made when trying to explain a broad ligament pregnancy to a patient with bilateral 
salpingectomy who had intercourse the day after follicular aspiration [10].
Finally it has to be mentioned that Deshpande et al. in 1999 reported a twin 
pregnancy in the broad ligament to a patient who underwent in vitro fertilization 
[12], while in 2001, Phupong et al. reported a twin pregnancy in the broad ligament 





There is a wide range of symptoms which can lead a patient to seek help and find 
out that she is pregnant with an ectopic pregnancy. Most of the symptoms are the 
same as for every other ectopic pregnancy, with abdominal pain and vaginal bleed-
ing to be the most prominent. The abdominal pain can be severe and of sudden 
onset [14] or intermittent and associated with other symptoms [15]. The pain can 
also be characterized as “mild” or “moderate” [16, 17] or just a “discomfort” [18], 
or finally it can be gradually increased in intensity [19]. The location of the pain has 
also to be reported to be related with the side of the ectopic pregnancy [19–21]. The 
duration of the pain can also vary between different cases, with even an extreme 
case of 4 months of intermittent pain to have been reported [22]. Finally it is not 
unusual for a broad ligament pregnancy to be completely asymptomatic and to be 
found during an early routine visit [11, 12].
The vaginal bleeding, if present, can also be of different severities. Cases with 
just vaginal spotting [21, 23, 24] have been reported, while in other reported cases, 
vaginal bleeding was present and more severe [22, 25–31], leading the patient to 
seek medical assistance.
Other symptoms that have been reported in an early broad ligament pregnancy 
include nausea [20, 24, 32], chills and fever [20], vomiting [20, 28], and dysuria 
[15]. These symptoms can be present alone or accompanying others, with various 
severities and to be evaluated as important or of no importance by the patient.
Despite the modern techniques and progress, there are places (more often in the 
developing world) where a pregnant woman cannot have access to proper antenatal 
care, making possible for an intraligamentary pregnancy to advance. In such a case, 
it is possible for the pregnant woman to seek help because of inability to perceive 
fetal movement [33, 34] or to be referred to a more specialized hospital due to 
severe oligamnion [35, 36] or intrauterine growth retardation [35]. Abdominal pain 
and vaginal bleeding are other possible symptoms for an advanced intraligamentary 
pregnancy like any other ectopic pregnancy.
It is also possible for a broad ligament pregnancy to have no symptom at all and 
to be found during a routine visit. Suchánková et al. reported a case where a patient 
with bilateral salpingectomy was referred to hospital from an assisted reproduction 
center to solve suspicion of molar intrauterine pregnancy, while the ultrasound 
and the following laparoscopy revealed a right broad ligament pregnancy [37]. 
Apantaku et al. in 2006 presented a case where a broad ligament pregnancy was 
discovered during a routine visit of a patient who had an IVF 6 weeks earlier [11], 
while Deshpande et al. in 1999 presented the first case of a twin broad ligament 
pregnancy 7 weeks after IVF [12]. Siow et al. in 2004 reported a case of a 10-week 
asymptomatic woman who presented for routine antenatal care and was found with 
a right adnexal mass and empty uterus. This was also the first published broad liga-
ment pregnancy which was managed laparoscopically [38]. Laparoscopy was also 
used to treat another case presented by Cosentino et al. in 2017 of an asymptomatic 
woman who presented to be submitted to a noninvasive prenatal diagnosis proce-
dure and was found to have a broad ligament pregnancy [39].
Finally there have been reported cases where the pregnancy went uneventfully 
until term. Seckin et al. in 2011 reported a case with a primigravid patient who 
was admitted due to breech presentation and oligamnion. Because of the breech 
presentation, they decided to proceed with primary cesarean section, where an 
unruptured gestational sac was found between the layers of the broad ligament with 
both adnexa being normal [36]. In another case report by Schramm in 1982, a case 
of a patient who presented with pains every 4–5 minutes for 1 hour was described. 
Another three mild contractions the next 90 minutes were recorded, and after that 
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it was difficult to identify the fetal lie and a definite uterine outline. Emergency 
laparotomy was carried out, and the placenta was found to be attached to the ante-
rior layer of the broad ligament [40]. The above cases were with favorable result; 
both mother and child survived through gestation and birth. Rakotomahenina et al. 
in 2014 reported a post-term pregnancy in the right broad ligament. The patient was 
not followed up during gestation and presented to the hospital at the 44th week. 
The fetus was dead in transversal position and was extracted from the right broad 
ligament by laparotomy [41]. This case showed that a broad ligament pregnancy can 
reach term without any serious symptoms.
From the above it can be concluded that a broad ligament pregnancy can present 
with a variety of symptoms or no symptom at all. When preparing for an opera-
tive solution for an ectopic pregnancy, the clinician must be prepared for this rare 
presentation, and it needs a high level of suspicion. When conservative manage-
ment with methotrexate is chosen for an ectopic pregnancy and does not have the 
expected results, broad ligament pregnancy should also be part of the differential 
diagnosis.
5. Diagnosis
The diagnosis of an ectopic pregnancy located in the broad ligament is difficult 
to be established preoperatively. In most cases the broad ligament diagnosis is done 
during the operation for a misdiagnosed tubal pregnancy, which can be either by 
laparotomy or laparoscopy. In this case the pregnancy can be found laterally to the 
uterus, medial to the pelvic side walls, superior to the pelvic floor, and inferior to 
the fallopian tube [42].
Ultrasound, transvaginal or abdominal, is the method of choice to identify the 
location of an ectopic pregnancy. If finding the site of an ectopic pregnancy is dif-
ficult, the easiest way to rule out an ectopic pregnancy is to identify an intrauterine 
one [43], something almost 100% possible in a gestation greater than 5,5 weeks [44, 
45]. An empty uterus with positive pregnancy test and the presence of a gestational 
sac or mass outside the uterus gives high suspicion for ectopic pregnancy [46]. A 
broad ligament pregnancy can grow significantly before giving any symptoms [47], 
in which the size can lead to distorted anatomy and increased difficulty in making 
an accurate diagnosis [48]. Phupong et al. in 2003 based on an empty uterus, a mass 
with a single viable fetus in a gestational sac located just beside the right side of the 
lower part of the uterus, and the clinical findings and their experience in a previ-
ous managed case, they reported a correct preoperative diagnosis by transvaginal 
ultrasound [31]. These two findings (empty uterus and an ectopic pregnancy mass 
just beside the lower part of the uterus when using transvaginal ultrasound) are 
two suggested ultrasonographic clues which can make the clinician suspect a broad 
ligament pregnancy [31]. Also in 2001 Sharma et al. reported that they managed 
to diagnose preoperatively a broad ligament pregnancy based on the anterior place 
with peritoneal reflection of the placenta combined with free fluid in the abdominal 
cavity and a bulky with thick endometrium uterus [28]. Allibone et al. in 1981 [49] 
suggested six criteria in order to assist the identification of an abdominal preg-
nancy: (a) demonstration of a fetus in a gestational sac outside the uterus, or the 
depiction of an abdominal or pelvic mass, identifiable as the uterus, separate from 
the fetus [49, 50], (b) failure to see a uterine wall between the fetus or products of 
conception and the urinary bladder, (c) recognition of a close approximation of 
fetal parts to the maternal abdominal wall, or gestational products like the placenta, 
both features alerting the sonographer to the absence of enveloping uterine walls, 




localization of the placenta outside the confines of the uterine cavity, (f) visual-
ization of the placenta immediately adjacent to the fetal chest and head with no 
intervening amniotic fluid [51].
Magnetic resonance imaging (MRI) can offer great help to the diagnosis of an 
ectopic pregnancy, especially when then location is unknown. MRI can also offer 
valuable information for the preoperative planning so as to avoid cutting in the 
placenta and reduce the bleeding during surgery [52, 53]. MRI can also highlight 
the involvement of pelvic structures and organs in an ectopic pregnancy, providing 
more helpful data to the preoperative planning [46]. Finally, it is also important to 
remember the contraindication of some contrast agents in pregnancy, which has to 
be considered when the life of the mother is at risk. In any case an informed consent 
should be obtained by the patient [54].
Angiogram is another tool which can prove its usefulness preoperatively, in 
order to reveal the location of the placental vessels, while embolization and pre- or 
postoperative can be used to control hemorrhage. Embolization could also be 
used for difficult-to-reach vessels intraoperatively [49, 55], although the location 
of a broad ligament pregnancy and the fact that such a pregnancy as often as not 
presents with acute abdomen limit the possible use of the above techniques.
6. Management
The rarity of this type of ectopic pregnancy makes it impossible to have prospec-
tive trials so as to conclude the best possible treatment. The reported cases that 
already can be found in the international medical literature can propose different 
management options [56], taking into consideration the different means every 
managing clinician can use.
Broad ligament pregnancies are difficult to be diagnosed before the time of 
surgical management. Therefore, methotrexate cannot be considered the first-line 
treatment for these conditions but may have been initiated if diagnosed incor-
rectly as tubal pregnancies [22, 57]. Despite that, Direkvand-Moghadam et al. in 
2015 reported a case where they treated a left broad ligament pregnancy with a 
single dose of methotrexate in a patient with left abdominal pain, 33 days since last 
menstrual period, β-hcg = 212 IU.L, and no abnormal sonographic findings. The 
maximum level of β-hcg was 659 IU.L, the forty sixth day after the last menstrual 
period, and returned to normal 3 weeks after the injection [21].
The way a patient with broad ligament pregnancy presents (abdominal pain in 
the first trimester) makes it very difficult to follow conservative treatment in order 
to achieve a favorable result such a live birth. Cachón López et al. in 1989 reported 
such a case of an 18-year-old woman diagnosed with a 30.4 week abdominal preg-
nancy. The diagnosis was established by clinical and imaging tests. They decided 
to keep the patient under close surveillance for 2 weeks and to induce fetal lung 
maturation. At 32.4 weeks of gestation, a laparotomy was performed giving birth 
to a 1.100gr baby. The placenta was found on the surface of the anterior leaf of the 
broad ligament and was removed together with the right salpinx [58].
Laparoscopic management of a broad ligament pregnancy is not impossible, and 
it has many advantages as shown by the laparoscopic management of abdominal 
pregnancies in other unusual sites. These advantages include the faster recovery of 
the patient, the lower surgical morbidity, and the better control of the blood loss 
[38]. It can be considered when the size is small [23, 59] and the patient stable. The 
presence of proficient laparoscopists and the option to convert to laparotomy at 
any time are also crucial [38]. Olsen in 1997 reported the first case of a successful 
laparoscopic management of a broad ligament pregnancy [23], while in 2004 Siow 
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et al. reported a successful laparoscopic management of a pregnancy presenting 
with a 6.5 cm mass. Siow et al. injected vasopressin into the broad ligament before 
starting the excision, the pregnancy was removed, and the surgery was completed 
uncomplicated [38]. Since then there has been an increase in the reports of broad 
ligament pregnancies which were managed with laparoscopy [11, 17, 24, 25, 30, 
60–62], while Mo et al. in 2018, in the case they reported, managed laparoscopically 
a broad ligament pregnancy with a hemoperitoneum of about 2800 ml. In most 
cases coagulation was used to control the breeding. Cheung et al. in 2014 reported 
that they needed to use three 1-0 Biosyn stitches in order to close the implantation 
site inside the broad ligament, so as to control the bleeding [17], while Kar in 2012 
used superficial infiltration of Pitressin (vasopressin) so as to control the hemor-
rhage from the base [62]. Finally in a case report by Yang et al. in 2017, they used 
absorbable hemostatic cellulose which was inserted into the retroperitoneal space in 
order to prevent bleeding [63].
Despite the extensive use of laparoscopy and the willingness to treat an ectopic 
pregnancy with more conservative ways, explorative laparotomy is still the way 
most cases are treated. The presentation to the hospital—most common with 
abdominal pain—of a missed broad ligament pregnancy plays an important role to 
this. Laparotomies have been reported in order to treat a wide spectrum of broad 
ligament pregnancies, starting with 5 weeks of amenorrhea [60], till broad ligament 
pregnancies at term [15, 36] which were admitted for an emergency cesarian sec-
tion. Finally a case of a post-term broad ligament pregnancy has been reported [41].
In the published medical literature, different outcomes for women who under-
went laparotomy or laparoscopy for a broad ligament pregnancy can also be found. 
There have been reported cases where the size of the pregnancy made it possible to 
be removed without any damage to the surrounding organs [10–12, 14, 15, 17, 19–26, 
33, 36–38, 41, 60–62, 64–66], where in other cases salpingectomy [18, 27, 31, 32, 40, 
56, 58, 67], oophorectomy [30], or salpingo-oophorectomy [28, 34, 35, 39] was nec-
essary to be performed due to the damage these organs presented. There have also 
been reported cases where the need for hysterectomy presented [20, 29, 40, 68], 
and finally in a report by Wolfe and Neigus in 1953, among three cases reported, the 
two patients died [20]. The above show that a broad ligament pregnancy can be a 
life-threatening situation or a cause of a serious disability, especially when exci-
sion of ovaries or the uterus is a necessity in order to save the patient. It also makes 
it necessary to inform the patient before the operation of the possible outcomes, 
especially when the suspicion of a broad ligament pregnancy is present.
Finally, the fact that a missed broad ligament pregnancy can present from an 
early week of amenorrhea or it can reach term and post-term, with a great range 
of symptoms (from none to very acute) makes the broad ligament pregnancy part 
of the differential diagnosis of nearly every pregnant woman presenting to the 
emergency room, no matter in which week of pregnancy she is. In the case that a 
broad ligament pregnancy is considered to be a possibility, it is important for the 
managing surgeon to gather the best available team. Because of the complexity of 
these cases, this team cannot be limited to gynecologists but should also include—if 
possible—general surgeons, urologists, and interventional radiologists. Each one of 
them can play an important role to the management of a broad ligament pregnancy 
depending on the size of the pregnancy and the damage to the surrounding organs.
7. Conclusions
An ectopic pregnancy located between the leaves of the broad ligament is a rare 




can be easily missed is it can cause worrying symptoms in any week of pregnancy, 
or it can go uneventful till term makes it a possibility in differential diagnosis of 
almost every pregnant woman presenting to the emergencies. The diagnosis preop-
eratively is also difficult to be established. MRI can play an important role if there 
is ultrasound suspicion for a broad ligament pregnancy. It must also be mentioned 
that, although there is growing need to manage ectopic pregnancies with minimal 
invasive techniques, methotrexate cannot be considered a first-line treatment for 
this type of ectopic pregnancy. On the other hand, there are numerous reports, and 
becoming more often every year, of broad ligament pregnancies managed laparo-
scopically. Finally, every gynecologist or surgeon who must operate a woman with a 
suspicion of a broad ligament pregnancy must provide the patient the best informa-
tion for possible excision of organs crucial to reproduction.
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